腫瘍病理鑑別診断アトラス　大腸癌　第2版

出版社： 文光堂
著者：
発行日： 2021-04-14
分野： 臨床医学：基礎  >  臨床病理学
ISBN： 9784830622588
シリーズ： 腫瘍病理鑑別診断アトラス
電子書籍版： 2021-04-14 （第2版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

17,600 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

17,600 円(税込)

購入する

商品紹介

腫瘍病理鑑別診断アトラスシリーズ「大腸癌」，待望の第2版．大腸癌の病理診断は，近年の内視鏡治療や分子病理学的解析の進歩に伴い，重要性が一層増している．また，tumor budding像や低分化胞巣などの新しい組織予後因子，炎症性腸疾患（IBD）に発生する異形成や癌など，日々トピックも更新されている．本書は，豊富な病理写真とともに，診断の要点や鑑別のポイントを解説．大腸癌病理診断の標準化を図りつつ，内視鏡診断と病理診断の接点，治療効果判定などの臨床と病理の連携にも言及した．病理医のみならず，臨床医にとっても大腸癌の理解の一助となる1冊．

目次

  • 第1部　検鏡前の確認事項
    　I．大腸癌取扱い規約のコンセプト：国際分類との相違を含めて
    　II．切除標本の取扱い方
    　III．肉眼診断
    　IV．結腸・直腸・肛門の解剖学・組織学

    第2部　組織型と鑑別診断
    　I．良性上皮性腫瘍
    　　1．管状腺腫・管状絨毛腺腫・絨毛腺腫
    　　2．鋸歯状病変
    　II．悪性上皮性腫瘍
    　　1．腺癌
    　　　1．乳頭腺癌・管状腺癌
    　　　2．低分化腺癌
    　　　3．粘液癌
    　　　4．印環細胞癌
    　　　5．髄様癌
    　　2．特殊型組織型
    　　　1．カルチノイド腫瘍と内分泌細胞癌
    　　　2．腺扁平上皮癌・扁平上皮癌
    　　　3．未分化癌
    　　　4．AFP産生腺癌
    　　　5．絨毛癌
    　　　6．癌肉腫
    　III．非上皮性腫瘍（間葉系腫瘍）
    　IV．リンパ腫と関連疾患
    　V．遺伝性大腸癌およびポリポーシス
    　　1．家族性大腸腺腫症
    　　（1）臨床
    　　（2）病理
    　　2．Lynch症候群
    　　（1）臨床
    　　（2）病理
    　　3．その他のポリポーシス
    　　（1）臨床
    　　（2）病理
    　VI．腫瘍様病変
    　VII．IBD dysplasia/cancer
    　VIII．肛門管腫瘍
    　IX．転移性腫瘍

    第3部　病理診断の実際
    　I．病理診断報告書に必要な記載
    　II．desmoplastic reactionの診断意義
    　III．大腸癌における組織学的予後因子
    　IV．生検診断の難しい検体の判定：生検の運用法を含めて
    　V．内視鏡切除検体の組織診断

    第4部　臨床との連携
    　I．早期病変における内視鏡診断と病理診断の接点
    　II．薬物や放射線療法後の病理組織判定のポイント
    　III．大腸癌切除後のサーベイランスと多重がん
    　IV．大腸癌治療ガイドラインの概要
    　V．大腸癌遺伝子検査と分子標的治療

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1部 検鏡前の確認事項

P.10 掲載の参考文献
1) 大腸癌研究会編 : 大腸癌取扱い規約, 第7版, 金原出版, 2006
 
2) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
3) Brierley JD, Gospodarowicz MK, Wittekind C : TNM Classification of Malignant Tumours (8th ed.), Wiley-Blackwell, UK, 2017
 
4) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours : Digestive System Tumours (5th ed.), IARC, Lyon, 2019
 
5) 大腸癌研究会編 : 大腸癌治療ガイドライン 医師用 2019年版, 金原出版, 2019 (http://www.jsccr.jp/guideline/2019/index_guide.html) [2021年3月閲覧]
 
P.17 掲載の参考文献
1) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
2) 田中学, 入江太朗, 中里洋一他 : 切り出し図における標本作製面の図示に関して. 病理と臨床 27 : 596, 2009
Medical*Online
3) 味岡洋一 : 小腸・虫垂・大腸・肛門. 病理と臨床 26 (臨増) : 154-159, 2008
 
4) 大倉康男 : 外科的切除材料及びEMRの固定方法と切り出し方法. 胃と腸 33 : 913-922, 1998
 
5) 二村聡, 岩下明徳, 津田純郎他 : 側方発育型大腸腫瘍の病理診断. 病理と臨床 25 : 653-663, 2007
 
P.27 掲載の参考文献
1) 小山恒男 : ESD時代の病理診断-臨床医からの要望-. 病理と臨床 25 : 634-639, 2007
Medical*Online
2) 牛尾恭輔 : 早期大腸癌の肉眼的分類-早期胃癌肉眼型分類との整合性を求めて. 胃と腸 35 : 1465-1476, 2000
 
3) The Paris endoscopic classification of superficial neoplastic lesions : esophagus, stomach, and colon : November 30 to December 1, 2002. Gastrointest Endosc 58 (6 Suppl) : S3-43, 2003
 
4) 工藤進英, 牛山信, 三浦宏二他 : 平坦・陥凹型大腸早期癌-sm浸潤形式, 発育進展を中心に-. 消化器外科 14 : 277-295, 1991
 
5) 工藤進英, 原栄志 : 平坦・陥凹型大腸癌の歴史と臨床 : 形態学的特徴を含めて. 日消誌 99 : 463-468, 2002
Medical*Online
6) 工藤進英, 石田文生, 池原伸直 : 陥凹型早期大腸癌の総括. 武藤徹一郎監修, 大腸疾患NOW 2010 特別号, 日本メディカルセンター, 2010, pp33-42
 
7) 山野泰穂, 工藤進英, 為我井芳郎他 : 大腸腫瘍性病変の肉眼形態分類. 胃と腸 35 : 1485-1490, 2000
 
8) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018, pp9-10, pp34-35, pp40-49
 
9) 多田正大 : 肉眼型分類の基本. 胃と腸 45 : 608-612, 2010
 
10) 清水辰一郎, 小池盛雄, 船田信顕他 : 早期大腸癌肉眼分類-早期胃癌肉眼分類との整合性を求めて. 胃と腸 35 : 1477-1483, 2000
 
11) 鶴田修, 河野弘志, 長谷川申他 : IIc病変とは. 胃と腸 45 (増刊) : 613-618, 2010
 
12) 藤吉学, 白水和雄, 梶原賢一郎他 : 腫瘤型大腸癌47例の臨床病理学的検討. 日消外会誌 22 : 2398-2403, 1989
 
13) 池上雅博, 下田忠和, 小牧稔之他 : 大腸sm癌の肉眼的特徴とその診断. 胃と腸 29 : 1237-1247, 1994
 
14) 伴慎一 : 粘膜内隆起性増殖を主体とする大腸sm癌の形態について. 早期大腸癌 2 : 455-458, 1998
 
15) 増田英樹, 林成興, 中村陽一他 : 腫瘤型大腸癌50例の臨床病理学的検討-潰瘍型大腸癌との比較や亜型分類について-. 日本大腸肛門病会誌 46 : 129-135, 1993
 
16) 鵜飼克行, 太田博俊, 上野雅資他 : びまん浸潤型大腸癌の臨床病理学的検討-進展様式による分類とその臨床病理学的特徴-. 日本大腸肛門病会誌 45 : 843-850, 1992
 
17) 平川克哉, 飯田三雄, 松本主之他 : 4型大腸癌の臨床病理学的特徴とX線・内視鏡診断-浸潤様式との関係を中心に. 胃と腸 37 : 152-164, 2002
 
18) 田中信治 : 隆起型早期大腸癌の病態と診断. 胃と腸 54 : 805-809, 2019
 
19) 長廻紘編 : 早期大腸癌-発生から診断・治療まで, 医学書院, 1993, pp123-153, pp155-182
 
20) Ikegami M : A pathological study on colorectal cancer. From de novo carcinoma to advanced carcinoma. Acta Pathol Jpn 37 : 21-37, 1987
 
21) Shimoda T, Ikegami M, Fujisaki J et al : Early colorectal carcinoma with special reference to its development de novo. Cancer 64 : 1138-1146, 1989
PubMed
22) 池上雅博 : PG, NPG分類からみた早期大腸癌の発育様式. 胃と腸 45 : 715-719, 2010
 
23) 岩下明徳, 山田豊, 八尾隆史他 : 大腸の結節集簇様病変の臨床病理学的検索. 胃と腸 27 : 409-419, 1992
 
24) 岡志郎, 田中信治, 大庭さやか他 : 側方発育型腫瘍 (LST) とは. 胃と腸 45 : 619-623, 2010
 
25) 長谷川申, 鶴田修, 河野弘志他 : 深達度診断からみた側方発育型大腸腫瘍 (LST) の分類と意義-内視鏡診断の立場から : 通常観察からみたLSTの深達度診断. 胃と腸 45 : 959-968, 2010
 
26) Jackman RJ, Beahrs OH : Tumors of the Large Bowel, W. B. Saunders, Philadelphia, 1968, pp131-145
 
27) 伴慎一, 大倉康男, 中村恭一 : 大腸villous tumorの病理組織学的特徴と組織診断. 早期大腸癌 5 : 81-93, 2001
 
28) 原岡誠司, 岩下明徳, 八尾隆史 : 大腸villous tumor-定義と問題点. 早期大腸癌 5 : 9-22, 2001
 
29) 松田尚久, 福澤誠克, 浦岡俊夫他 : 有茎性大腸SM癌のリンパ節転移・再発. 多施設384例の検討. 武藤徹一郎監修, 大腸疾患NOW 2010 特別号, 日本メディカルセンター, 2010, pp82-89
 
30) 大腸癌研究会編 : 大腸癌治療ガイドライン 医師用 2019年版, 金原出版, 2019 (http://www.jsccr.jp/guideline/2019/index_guide.html) [2021年3月閲覧]
 
31) 和田了, 浜谷茂治 : 大腸sm癌の肉眼的特徴. 早期大腸癌 2 : 451-453, 1998
 
32) 伴慎一 : 大腸癌の病理診断-日常診断で気をつける点-. 病理と臨床 29 : 1094-1104, 2011
Medical*Online
P.35 掲載の参考文献
1) Westerhoff M, Greenson JK : Colon. in Mills SE (ed) : "Histology for pathologists" (5 th ed.), Wolters Kluwer, Philadelphia, 2020, pp640-663
 
2) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
3) Pittmann ME, Yantiss RK : Anal canal. in Mills SE (ed) : "Histology for pathologists" (5 th ed.), Wolters Kluwer, Philadelphia, 2020, pp677-691
 
4) Hutchins G, West NP, Quirke P : Normal large intstine : anatomy, specimen dissection and histology relevant to pathological practice. in Shepherd NA, Warren BF, Williams GT, et al (eds) : Morson and Dowson's Gastrointestinal pathology (5th ed.), Wiley-Blackwell, Hoboken, 2013, pp511-523
 
5) Torlakovic EE, Gomez JD, Driman DK et al : Sessile serrated sdenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 32 : 21-29, 2008
PubMed
6) Arai T, Kino I : Morphometrical and cell kinetic studies of normal human colorectal mucosa. Comparison between the proximal and the distal large intestine. Acta Pathol Jpn 39 : 725-730, 1989
PubMed
7) Lee E, Schiller LR, Fordtran JS : Quantification of colonic lamina propria cells by means of a morphometric pointcounting method. Gastroenterology 94 : 409-418, 1988
 
8) Kirby JA, Bone M, Robertson H, et al : The number of intraepithelial T cells decrease from ascending colon to rectum. J Clin Pathol 56 : 158, 2003
 
9) Walker NI, Bannett RE, Axelsen RA : Melanosis coli. A consequence of anthraquinone-induced apoptosis of colonic epithelial cells. Am J Pathol 131 : 465-476, 1988
 
10) Fenger C, Nielsen K : Stereomicroscopic investigation of the anal canal epithelium. Scand J Gastroenterol 17 : 571-575, 1982
PubMed

第2部 組織型と鑑別診断

P.42 掲載の参考文献
1) Hamilton SR, Sekine S : Conventional colorectal adenoma. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours : Digestive System Tumours" (5 th ed.), IARC, Lyon, 2019, pp170-173
 
2) 小嶋基寛 : 大腸粘膜内癌の診断基準と問題点. 胃と腸 54 : 1485-1490, 2019
 
3) Morson BBC, Dawson IMP : Benign epithelial tumours and polyps. in Day DW, Jass JR, Price AB et al (eds) : "Morson and Dawson's Gastrointestinal Pathology", Blackwell, London, 2003, pp563-595
 
4) Lambert R, Kudo SE, Vieth M et al : Pragmatic classification of superficial neoplastic colorectal lesions. Gastrointest Endosc 70 : 1182-1199, 2009
PubMed
5) Laird-Fick HS, Chahal G, Olomu A et al : Colonic polyp histopathology and location in a community-based sample of older adults. BMC Gastroenterol 16 : 90, 2016
 
6) Clark JC, Collan Y, Eide TJ et al : Prevalence of polyps in an autopsy series from areas with varying incidence of largebowel cancer. Int J Cancer 36 : 179-186, 1985
 
7) Gerharz CD, Gabbert H, Krummel F : Age-dependent shift-to-the-right in the localization of colorectal adenomas. Virchows Arch A 411 : 591-598, 1987
 
8) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
9) Kim MJ, Lee EJ, Chun SM et al : The significance of ectopic crypt formation in the differential diagnosis of colorectal polyps. Diagn Pathol 9 : 212, 2014
PubMed
10) International Collaboration on Cancer Reporting : www.iccr-cancer.org
 
11) Schlemper RJ, Riddell RH, Kato Y et al : The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47 : 251-255, 2000
PubMed
12) Saito T, Niida A, Uchi R et al : A temporal shift of the evolutionar y principle shaping intratumor heterogeneity in colorectal cancer. Nat Commun 9 : 2884, 2018
 
P.52 掲載の参考文献
1) Murakami T, Sakamoto N, Nagahara A : Clinicopathological features, diagnosis, and treatment of sessile serrated adenoma/polyp with dysplasia/carcinoma. J Gastroenterol Hepatol 34 : 1685-1695, 2019
PubMed
2) Matsuda T, Fujii T, Sano Y et al : Five-year incidence of advanced neoplasia after initial colonoscopy in Japan : a multicenter retrospective cohort study. Jpn J Clin Oncol 39 : 435-442, 2009
PubMed
3) Nagtegaal ID, Arends MJ, Odze RD et al (eds) : Tumors of the colon and rectum. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours : Digestive System Tumours" (5 th ed.), IARC, Lyon, 2019, pp158-191
 
4) Jass JR, Whitehall VL, Young J et al : Emerging concepts in colorectal neoplasia Gastroenterology 123 : 862-876, 2002
PubMed
5) 菅井有, 山本英一郎, 木村友昭他 : 大腸鋸歯状病変の臨床病理と分子異常. 日消誌 112 : 661-668, 2015
Medical*Online
6) 菅井有, 山野泰穂, 木村友昭他 : 大腸鋸歯状病変の臨床病理学的特徴および分子病理学的意義. 胃と腸 46 : 373-383, 2011
 
7) Leggett B, Whitehall V : Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138 : 2088-2100, 2010
PubMed
8) 菅井有, 永塚真, 田中義人 : 大腸 (特集 : 消化管粘膜内腫瘍の見方, 考え方, そのエビデンス). 病理と臨床 37 : 748-756, 2019
 
9) Hashimoto T, Tanaka Y, Ogawa R et al : Superficially serrated adenoma : a proposal for a novel subtype of colorectal serrated lesion. Mod Pathol 31 : 1588-1598, 2018
PubMed
10) Tanaka Y, Eizuka M, Uesugi N et al : Traditional serrated adenoma has two distinct genetic pathways for molecular tumorigenesis with potential neoplastic progression. J Gastroenterol 55 : 846-857, 2020
PubMed
11) Hashimoto T, Yamashita S, Yoshida HT et al : WNT pathway gene mutations are associated with the presence of dysplasia in colorectal sessile serrated adenoma/polyps. Am J Surg Pathol 41 : 1188-1197, 2017
 
12) Sugai T, Eizuka M, Habano W et al : Comprehensive molecular analysis based on somatic copy number alterations in intramucosal colorectal neoplasias and early invasive colorectal cancers. Oncotarget 9 : 22895-22906, 2018
PubMed
13) 永塚真, 菅井有, 荒川典之他 : 発生部位に基づいた大腸鋸歯状病変の臨床病理学的および分子病理学的検討. 胃と腸 50 : 1709-1722, 2015
 
14) Sugai T, Eizuka M, Fujita Y et al : Molecular profiling based on KRAS/BRAF mutation, methylation, and microsatellite statuses in serrated lesions. Dig Dis Sci 63 : 2626-2638, 2018
PubMed
15) Gonzalo DH, Lai KK, Shadrach B et al : Gene expression profiling of serrated polyps identifies annexin A10 as a marker of a sessile serrated adenoma/polyp. J Pathol 230 : 420-429, 2013
PubMed
16) Cancer Genome Atlas Network : Comprehensive molecular characterization of human colon and rectal cancer. Nature 487 : 330-337, 2012
PubMed
17) Lengauer C, Kinzler KW, Vogelstein B : Genetic instability in colorectal cancers. Nature 386 : 623-627, 1997
PubMed
18) Eizuka M, Kawasaki K, Toya Y et al : Colorectal Adenocarcinoma with an Alternative Serrated Pathway. Case Rep Gastroenterol 12 : 116-124, 2018
PubMed
19) Lin CC, Lin JK, Lin TC et al : The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer. J Surg Oncol 110 : 451-457, 2014
PubMed
20) Zlobec I, Lugli A : Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer : tumor budding as oncotarget. Oncotarget 1 : 651-661, 2010
 
21) Andersen SH, Lykke E, Folker MB et al : Sessile serrated polyps of the colorectum are rare in patients with Lynch syndrome and in familial colorectal cancer families. Fam Cancer 7 : 157-162, 2008
PubMed
22) Hiromoto T, Murakami T, Akazawa Y et al : Immunohistochemical and genetic characteristics of a colorectal mucinrich variant of traditional serrated adenoma. Histopathology 73 : 444-453, 2018
PubMed
23) Kalimuthu S, Serra S, Hafezi-Bakhtiari S et al : Mucin-rich variant of traditional serrated adenoma : a distinct morphological variant. Histopathology 71 : 208-216, 2017
 
24) Bettington M, Walker N, Rosty C et al : Serrated tubulovillous adenoma of the large intestine. Histopathology 68 : 578-587, 2016
PubMed
25) Liu C, McKeone DM, Walker NI et al : GNAS mutations are present in colorectal traditional serrated adenomas, serrated tubulovillous adenomas and serrated adenocarcinomas with adverse prognostic features. Histopathology 70 : 1079-1088, 2017
PubMed
P.59 掲載の参考文献
1) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours : Digestive System Tumours (5th ed.), IARC, Lyon, 2019
 
2) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
3) Gonzalez RS, Cates JMM, Washington MK et al : Adenoma-like adenocarcinoma : a subtype of colorectal carcinoma with good prognosis, deceptive appearance on biopsy and frequent KRAS mutation. Histopathology 68 : 183-190, 2016
 
4) Bayrak R, Haltas H, Yenidunya S : The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas : cytokeratin 7-/20+phenotype is more specific than CDX2 antibody. Diagn Pathol 7 : 9, 2012
PubMed
5) Moh M, Krings G, Ates D et al : SATB2 expression distinguishes Ovarian metastases of colorectal and appendiceal origin from primary Ovarian tumors of mucinous or endometrioid type. Am J Surg Pathol 40 : 419-432, 2016
PubMed
6) Dalerba P, Sahoo D, Paik S et al : CDX2 as a prognosic biomarker in Stage II and Stage III colon cancer. N Engl J Med 374 : 211-222, 2016
 
7) Schlemper RJ, Itabashi M, Kato Y et al : Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer 82 : 60-69, 1998
PubMed
8) Lengauer, C, Kinzler KW, Vogelstein B : Genetic instability in colorectal cancers. Nature 386 : 623-627, 1997
PubMed
9) Vogelstein B, Fearon ER, Hamilton SR et al : Genetic alteration during colorectal-tumor development. N Eng J Med 319 : 525-532, 1998
 
10) Jass JR, Whitehall VLJ, Young J et al : Emerging concepts in colorectal neoplasia. Gastroenterology 123 : 862-876, 2002
 
11) The Cancer Genome Atlas Network : Comprehensive molecular characterization of human colon and rectal cancer. Nature 487 : 330-337, 2012
 
12) Lievre A, Bachet JB, Le Corre DL et al : KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 66 : 3992-3995, 2006
 
13) Custem EV, Kohne CH, Hitre E et al : Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Eng J Med 360 : 1408-1417, 2009
 
14) Le DT, Uram JN, Wang H et al : PD-1 blockade in tumors with mismatch-repair deficiency. N Eng J Med 372 : 2509-2520, 2015
 
15) Le DT, Durham JN, Smith KN et al : Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357 : 409-413, 2017
 
P.64 掲載の参考文献
1) 大腸癌研究会編 : 大腸癌取扱い規約, 第7版補訂版. 金原出版, 2009
 
2) Hamilton SR, Aaltonen LA (eds) : WHO Classification of Tumours : Pathology and Genetics of Tumours of the Digestive System, IARC, Lyon, 2000
 
3) Clery AP, Dockerty MB, Waugh JM : Small cell carcinoma of the colon and rectum. A clinicopa thologic study. Arch Surg 1 : 164-172, 1961
 
4) 重松明博 : 低分化型大腸癌の臨床病理学的研究. 病理と臨床 3 : 1239-1249, 1985
 
5) 大塚正彦, 加藤洋 : 大腸の低・未分化癌の臨床病理学的検討-分類および内分泌細胞癌との関連について. 日消外会誌 25 : 1248-1256, 1992
 
6) 平井一郎, 池田栄一, 飯澤肇他 : 大腸低分化腺癌, 印環細胞癌の臨床病理学的検討. 日消外会誌 28 : 805-812, 1995
 
7) Goi T, Hirono Y, Katayama K et al : Microsatellite instability and survival rate in the solid or nonsolid types of poorly differentiated colorectal adenocarcinoma. Int Surg 89 : 100-106, 2004
PubMed
8) Masuda H, Abe Y, Takayama T : Microsatellite instability in poorly differentiated colorectal adenocarcinoma, particularly in relation to two subtypes. Hepatogastroenterology 52 : 82-85, 2005
PubMed
9) 大腸癌研究会編 : 大腸癌取扱い規約, 第7版. 金原出版, 2006
 
10) 大腸癌研究会編 : 大腸癌取扱い規約, 第8版. 金原出版, 2013
 
11) Taniyama K, Suzuki H, Matsumoto M et al : Flow cytometric DNA analysis of poorly differentiated adenocarcinoma of the colorectum. Jpn J Clin Oncol 21 : 406-411, 1991
PubMed
12) 出江洋介, 川崎恒雄, 丸山祥司他 : 大腸低分化型癌の臨床病理学的検討. 日消外医会誌 55 : 1385-1391, 1994
 
13) Arai T, Takubo K, Sawabe M et al : Pathologic characteristics of colorectal cancer in the elderly : a retrospective study of 947 surgical cases. J Clin Gastroenterol 31 : 67-72, 2000
 
14) 西村洋治, 関根毅, 小林照忠他 : 稀な大腸悪性腫瘍の臨床病理学的検討. 第54回大腸癌研究会アンケート調査報告. 日本大腸肛門病会誌 57 : 132-140, 2004
 
15) 大腸癌研究会編 : Multi-Institutional Registry of Large Bowel Cancer in Japan. Cases treated in 2007 (http://www.jsccr.jp/registration/pdf/Vol_33.pdf) [2021年3月閲覧]
 
16) Arai T, Esaki Y, Sawabe M et al : Hypermethylation of the hMLH1 promoter with absent hMLH1 expression in medullary-type poorly differentiated colorectal adenocarcinoma in the elderly. Mod Pathol 17 : 172-179, 2004
PubMed
17) 奥野匡宥, 池原照幸, 長山正義他 : 大腸低分化腺癌の臨床病理学的検討. 日臨外医会誌 50 : 1307-1312, 1989
 
18) 宮原栄治, 池尻公二, 前川宗一郎他 : 大腸低分化腺癌25例の臨床病理学的検討. 日消外会誌 25 : 1984-1988, 1992
 
19) Takeuchi K, Kuwano H, Tsuzuki Y et al : Clinicopathological characteristics of poorly differentiated adenocarcinoma of the colon and rectum. Hepatogastroenterology 51 : 1698-1702, 2004
PubMed
20) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
21) Ueno H, Hase K, Hashiguchi Y et al : Site-specific tumor grading system in colorectal cancer : multicenter pathologic review of the value of quantifying poorly differentiated clusters. Am J Surg Pathol 38 : 197-204, 2014
PubMed
22) 新井冨生, 櫻井うらら, 沢辺元司他 : 髄様型大腸低分化腺癌の病理学的特徴. 胃と腸 45 : 1837-1846, 2010
 
23) Nakahara H, Ishikawa T, Itabashi M et al : Diffusely infiltrating primary colorectal carcinoma of linitis plastica and lymphangiosis types. Cancer 69 : 901-906, 1992
PubMed
24) 小池盛雄, 滝沢登一郎, 舩田顕信他 : びまん浸潤型大腸癌の病理. 胃と腸 23 : 609-615, 1988
 
25) 二村聡, 富永健司, 関根茂樹他 : 4型大腸癌の病理学的特徴-浸潤形式とその組織型について. 胃と腸 37 : 137-151, 2020
 
26) 新井冨生, 櫻井うらら, 沢辺元司他 : 大腸低分化腺癌の亜分類の是非. 大腸癌FRONTIER 4 : 38-42, 2011
Medical*Online
27) Sakamoto K, Watanabe M, De La Cruz C et al : Primary invasive micropapillary carcinoma of the colon. Histopathology 47 : 479-484, 2005
 
28) Kim MJ, Hong SM, Jang SJ et al : Invasive colorectal micropapillary carcinoma : an aggressive variant of adenocarcinoma. Hum Pathol 37 : 809-815, 2006
PubMed
29) Barresi V, Branca G, Ieni A et al : Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer. Virchows Arch 464 : 655-662, 2014
PubMed
30) Kawabata Y, Tomita N, Monden T et al : Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum. Int J Cancer 84 : 33-38, 1999
PubMed
31) Imai Y, Yamagishi H, Fukuda K et al : Expression of cytokeratin 20 indicates invasive histological phenotype in poorly differentiated colorectal adenocarcinoma. Anticancer Res 34 : 159-167, 2014
PubMed
32) Ruschoff J, Dietmaier W, Luttges J et al : Poorly differentiated colonic adenocarcinoma, medullary type : clinical, phenotypic, and molecular characteristics. Am J Pathol 150 : 1815-1825, 1997
PubMed
33) Knox RD, Luey N, Sioson L et al : Medullary colorectal carcinoma revisited : a clinical and pathological study of 102 cases. Ann Surg Oncol 22 : 2988-2996, 2015
PubMed
34) Fiehn AM, Grauslund M, Glenthoj A et al : Medullary carcinoma of the colon : can the undifferentiated be differentiated? Virchows Arch 466 : 13-20, 2015
PubMed
35) Jass JR, Whitehall VL, Young J et al : Emerging concepts in colorectal neoplasia. Gastroenterology 123 : 862-876, 2002
PubMed
36) Makinen MJ : Colorectal serrated adenocarcinoma. Histopathology 50 : 131-150, 2007
PubMed
37) 大腸癌研究会編 : 遺伝性大腸癌診療ガイドライン, 2020年版, 金原出版, 2020
 
P.70 掲載の参考文献
1) 大腸癌研究会編 : 大腸癌取り扱い規約, 第9版, 金原出版, 2018
 
2) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours : Digestive System Tumours (5th ed.), IARC, Lyon, 2019, p180
 
3) Tozawa E, Ajioka Y, Watanabe H et al : Mucin expression, p53 overexpression, and peritumoral lymphocytic infiltration of advanced colorectal carcinoma with mucus component : is mucinous carcinoma a distinct histological entity? Pathol Res Pract 203 : 567-574, 2007
PubMed
4) 小松信男, 河村正敏, 横川京児他 : 粘液結節を有する大腸癌の臨床病理学的検討. 日臨外会誌 59 : 623-628, 1998
 
5) 西村洋治, 関根毅, 小林照忠他 : 稀な大腸悪性腫瘍の臨床病理学的検討 第54回大腸癌研究会アンケート調査報告. 日本大腸肛門病会誌 57 : 132-140, 2004
 
6) 牧野知紀, 三嶋秀行, 池永雅一他 : 大腸印環細胞癌の臨床病理学的検討. 日消外会誌 39 : 16-22, 2006
 
7) 能見伸八郎, 田中承男, 井口公雄他 : 大腸粘液癌の検討. 日消外会誌 15 : 1876-1880, 1982
 
8) Hogan J, Burke JP, Samaha G et al : Overall survival is improved in mucinous adenocarcinoma of the colon. Int J Colorectal Dis 29 : 563-569, 2014
PubMed
9) 池川隆一郎, 中江史朗, 中村毅他 : 分化度による亜分類からみた大腸粘液癌の臨床病理学的検討. 日本大腸肛門病会誌 52 : 98-106, 1999
 
10) 岩川和秀, 門多健, 清地秀典他 : 大腸粘液癌の臨床病理学的検討. 日消外会誌 27 : 1949-1953, 1994
 
11) 豊田和広, 岡島正純, 浅原利正他 : 大腸粘液癌の検討. 日本大腸肛門病会誌 47 : 324-330, 1994
 
12) 佐藤美信, 丸田守人, 前田耕太郎他 : 直腸および結腸粘液癌の臨床病理学的検討. 日本大腸肛門病会誌 52 : 676-683, 1999
 
13) Hugen N, Verhoeven RHA, Radema SA et al : Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma. Ann Oncol 24 : 2819-2824, 2013
 
14) Ko EY, Ha HK, Kim AY et al : CT differentiation of mucinous and nonmucinous colorectal carcinoma. AJR Am J Roentgenol 188 : 785-791, 2007
PubMed
15) 徳丸勝悟, 久保田仁, 鈴木秀昭他 : MRI検査が有用であった痔瘻癌の1例. 日臨外会誌 65 : 1008-1011, 2004
 
16) 大腸癌研究会編 : 大腸癌治療ガイドライン 医師用 2019年版, 金原出版, 2019 (http://www.jsccr.jp/guideline/2019/index_guide.html) [2021年3月閲覧]
 
17) Reynolds IS, O'Connell E, Fichtner M et al : Mucinous adenocarcinoma of the colon and rectum : a genomic analysis. J Surg Oncol 120 : 1427-1435, 2019
 
18) Arai T, Kasahara I, Sawabe M et al : Microsatellite-unstable mucinous colorectal carcinoma occurring in the elderly : comparison with medullary type poorly differentiated adenocarcinoma. Pathol Int 57 : 205-212, 2007
PubMed
19) Shin JH, Bae, JH, Lee A et al : CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma. Jpn J Clin Oncol 40 : 208-213, 2010
PubMed
20) Murakami T, Sakamoto N, Nagahara A : Clinicopathological features, diagnosis, and treatment of sessile serrated adenoma/polyp with dysplasia/carcinoma. J Gastroenterol Hepatol 34 : 1685-1695, 2019
PubMed
21) Jenkins MA, Hayashi S, O'Shea AM et al : Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability : a population-based study. Gastroenterol 133 : 48-56, 2007
 
22) 大腸癌研究会編 : 遺伝性大腸癌診療ガイドライン, 2020年版, 金原出版, 2020
 
23) 鈴木公孝, 渡邉聡明, 畑 啓介他 : 潰瘍性大腸炎の癌化とサーベイランスの検討-本邦報告例の解析-. 日本大腸肛門病会誌 56 : 62-68, 2003
 
24) Svrcek M, Cosnes J, Beaugerie L et al : Colorectal neoplasia in Crohn's colitis : a retrospective comparative study with ulcerative colitis. Histopathology 50 : 574-583, 2007
PubMed
P.73 掲載の参考文献
1) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
2) Nagtegaal ID, Arends MJ, Salto-Tellez M : Colorectal adenocarcinoma. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours : Digestive System Tumours" (5 th ed.), IARC, Lyon, 2019, pp177-187
 
3) Laufman H, Saphir O : Primary linitis plastica type of carcinoma of the colon. AMA Arch Surg 62 : 79-91, 1951
PubMed
4) Sasaki S, Masaki T, Umetani N et al : Characteristics in primary signet-ring cell carcinoma of the colorectum, from clinicopathological observations. Jpn J Clin Oncol 28 : 202-206, 1998
PubMed
5) 原口美明, 長濱徴, 冨木裕一他 : 大腸印環細胞癌の臨床病理学的検討. 日臨外医会誌 56 : 1811-1815, 1995
 
6) Makino T, Tsujinaka T, Mishima H et al : Primary signetring cell carcinoma of the colon and rectum : report of eight cases and review of 154 Japanese cases. Hepatogastroenterology 53 : 845-849, 2006
 
7) Mizushima T, Nomura M, Fujii M et al : Primary colorectal signet-ring cell carcinoma : clinicopathological features and postoperative survival. Surg Today 40 : 234-238, 2010
PubMed
8) 西村洋治, 関根毅, 小林照忠他 : 稀な大腸悪性腫瘍の臨床病理学的検討. 第54回大腸癌研究会アンケート調査報告. 日本大腸肛門病会誌 57 : 132-140, 2004
 
9) Yang LL, Wang M, He P : Clinicopathological characteristics and survival in colorectal signet ring cell carcinoma : a population-based study. Sci Rep 10 : 10460, 2020
PubMed
10) Belli S, Aytac HO, Karagulle E et al : Outcomes of surgical treatment of primary signet ring cell carcinoma of the colon and rectum : 22 cases reviewed with literature. Int Surg 99 : 691-698, 2014
PubMed
11) Ishihara S, Watanabe T, Akahane T et al : Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon. Int J Colorectal Dis 27 : 371-379, 2012
PubMed
12) Inamura K, Yamauchi M, Nishihara R et al : Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma. Ann Surg Oncol 22 : 1226-1235, 2015
PubMed
13) Terada T : An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum : II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases. Int J Clin Exp Pathol 6 : 613-621, 2013
PubMed
14) Kakar S, Smyrk TC : Signet ring cell carcinoma of the colorectum : correlations between microsatellite instability, clinicopathologic features and survival. Mod Pathol 18 : 244-249, 2005
PubMed
15) Alvi MA, Loughrey MB, Dunne P et al : Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies. Br J Cancer 117 : 203-209, 2017
 
16) Wei Q, Wang X, Gao J et al : Clinicopathologic and molecular features of colorectal adenocarcinoma with signet-ring cell component. PLoS One 11 : e0156659, 2016
 
17) Terada T : An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum : I. Cytokeratin profile in 42 cases. Int J Clin Exp Pathol 6 : 703-710, 2013
PubMed
18) Chu PG, Weiss LM : Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol 121 : 884-892, 2004
 
19) Terada T : An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum : III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases. Int J Clin Exp Pathol 6 : 630-638, 2013
PubMed
20) Kawabata Y, Tomita N, Monden T et al : Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum. Int J Cancer 84 : 33-38, 1999
PubMed
21) 出江洋介, 川崎恒雄, 丸山祥司他 : 大腸低分化型癌の臨床病理学的検討. 日臨外医会誌 55 : 1385-1391, 1994
 
22) Fu KI, Sano Y, Kato S et al : Primary signet-ring cell carcinoma of the colon at early stage : a case report and a review of the literature. World J Gastroenterol 12 : 3446-3449, 2006
 
P.80 掲載の参考文献
1) Hamilton SR, Aaltonen LA (eds) : WHO Classification of Tumours : Pathology and Genetics of Tumours of the Digestive System, IARC, Lyon, 2000
 
2) 大腸癌研究会編 : 大腸癌取扱い規約, 第8版, 金原出版, 2013
 
3) Nagtegaal ID, Arends MJ, Salto-Tellez M : Colorectal adenocarcinoma. in WHO Classificatoin of Tumours Editorial Board (ed) : "WHO Classification of Tumours : Digestive System Tumours" (5 th ed.), IARC, Lyon, 2019, pp177-187
 
4) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
5) Johnson JW, Judd ES, Dahlin DC : Malignant neoplasms of the colon and rectum in young persons. Arch Surg 79 : 365-372, 1959
PubMed
6) Clery AP, Dockerty MB, Waugh JM : Small-cell carcinoma of the colon and rectum. A clinicopathologic study. Arch Surg 83 : 164-172, 1961
PubMed
7) Gibbs NM : Undifferentiated carcinoma of the large intestine. Histopathology 1 : 77-84, 1977
PubMed
8) 重松明博 : 低分化型大腸癌の臨床病理学的研究. 病理と臨床 3 : 1239-1249, 1985
 
9) Ruschoff J, Dietmaier W, Luttges J et al : Poorly differentiated colonic adenocarcinoma, medullary type : clinical, phenotypic, and molecular characteristics. Am J Pathol 150 : 1815-1825, 1997
PubMed
10) Sugao Y, Yao T, Kubo C et al : Improved prognosis of solidtype poorly differentiated colorectal adenocarcinoma : a clinicopathological and immunohistochemical study. Histopathology 31 : 123-133, 1997
PubMed
11) Jessurun J, Romero-Guadarrama M, Manivel JC : Medullary adenocarcinoma of the colon : clinicopathologic study of 11 cases. Hum Pathol 30 : 843-848, 1999
PubMed
12) Lanza G, Gafa R, Matteuzzi M et al : Medullary-type poorly differentiated adenocarcinoma of the large bowel : a distinct clinicopathologic entity characterized by microsatellite instability and improved survival. J Clin Oncol 17 : 2429-2438, 1999
PubMed
13) Arai T, Esaki Y, Sawabe M et al : Hypermethylation of the hMLH1 promoter with absent hMLH1 expression in medullary-type poorly differentiated colorectal adenocarcinoma in the elderly. Mod Pathol 17 : 172-179, 2004
PubMed
14) Hinoi T, Tani M, Lucas PC et al : Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol 159 : 2239-2248, 2001
 
15) 新井冨生, 櫻井うらら, 沢辺元司他 : 髄様型大腸低分化腺癌の病理学的特徴. 胃と腸 45 : 1837-1846, 2010
 
16) Knox RD, Luey N, Sioson L et al : Medullary colorectal carcinoma revisited : a clinical and pathological study of 102 cases. Ann Surg Oncol 22 : 2988-2996, 2015
PubMed
17) Pyo JS, Sohn JH, Kang G : Medullary carcinoma in the colorectum : a systematic review and meta-analysis. Hum Pathol 53 : 91-96, 2016
PubMed
18) Thirunavukarasu P, Sathaiah M, Singla S et al : Medullary carcinoma of the large intestine : a population based analysis. Int J Oncol 37 : 901-907, 2010
PubMed
19) 新井冨生, 櫻井うらら, 沢辺元司他 : 大腸低分化腺癌の亜分類の是非. 大腸癌FRONTIER 4 : 38-42, 2011
Medical*Online
20) Graham DM, Appelman HD : Crohn's-like lymphoid reaction and colorectal carcinoma : a potential histologic prognosticator. Mod Pathol 3 : 332-335, 1990
PubMed
21) Arai T, Kasahara I, Sawabe M et al : Microsatellite-unstable mucinous colorectal carcinoma occurring in the elderly : comparison with medullary type poorly differentiated adenocarcinoma. Pathol Int 57 : 205-212, 2007
PubMed
22) Fiehn AM, Grauslund M, Glenthoj A et al : Medullary carcinoma of the colon : can the undifferentiated be differentiated? Virchows Arch 466 : 13-20, 2015
PubMed
23) Nguyen J, Coppola D, Shan Y et al : Poorly differentiated medullary carcinoma of the colon with an unusual phenotypic profile mimicking high grade large cell lymphoma-a unique case report and review of the literature. Int J Clin Exp Pathol 7 : 828-834, 2014
PubMed
24) Takahashi S, Kohashi K, Yamamoto H et al : Expression of adhesion molecules and epithelial-mesenchymal transition factors in medullary carcinoma of the colorectum. Hum Pathol 46 : 1257-1266, 2015
PubMed
25) 大腸癌研究会編 : 遺伝性大腸癌診療ガイドライン 2016年版, 金原出版, 2016
 
26) Renaud F, Vincent A, Mariette C et al : MUC5AC hypomethylation is a predictor of microsatellite instability independently of clinical factors associated with colorectal cancer. Int J Cancer 136 : 2811-2821, 2015
PubMed
27) Guinney J, Dienstmann R, Wang X et al : The consensus molecular subtypes of colorectal cancer. Nat Med 21 : 1350-1356, 2015
PubMed
28) Makinen MJ : Colorectal serrated adenocarcinoma. Histopathology 50 : 131-150, 2007
PubMed
29) Arai T, Takubo K : Clinicopathological and molecular characteristics of gastric and colorectal carcinomas in the elderly. Pathol Int 57 : 303-314, 2007
PubMed
30) Le DT, Uram JN, Wang H et al : PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 372 : 2509-2520, 2015
PubMed
31) Dudley JC, Lin MT, Le DT et al : Microsatellite instability as a biomarker for PD-1 blockade. Clin Cancer Res 22 : 813-820, 2016
PubMed
P.101 掲載の参考文献
1) Bosman FT, Carneiro F, Hruban RH et al (eds) : WHO Classification of Tumours of the Digestive System, IARC, Lyon, 2010, pp10-417
 
2) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours : Digestive System Tumours (5th ed.), IARC, Lyon, 2019, pp13-635
 
3) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018, pp56-92
 
4) 岩渕三哉 : 内分泌細胞腫瘍. 九嶋亮治, 牛久哲男編 : 腫瘍病理鑑別診断アトラス 十二指腸・小腸・虫垂腫瘍, 文光堂, 2021, pp92-109
 
5) 岩渕三哉, 佐野壽昭 : 消化管 (肝, 胆管を含む) 内分泌細胞腫瘍. 病理と臨床 17 : 1253-1262, 1999
Medical*Online
6) 岩渕三哉, 渡辺徹, 本間陽奈他 : 消化管内分泌細胞腫瘍の日本の分類と2010年WHO分類の対比. 胃と腸 48 : 941-955, 2013
 
7) 岩渕三哉 : カルチノイド腫瘍と内分泌細胞癌. 八尾隆史, 藤盛孝博編 : 腫瘍病理鑑別診断アトラス 大腸癌, 文光堂, 2011, pp75-90
 
8) 岩渕三哉, 須貝美佳, 林真也他 : 消化管内分泌細胞腫瘍の病理診断と諸問題-WHO分類と日本分類の相違. INTESTINE 23 : 15-25, 2019
 
9) 原岡誠司, 岩下明徳 : 消化管内分泌細胞腫瘍の病理学的特徴-下部消化管 (小腸・大腸) を中心に. 胃と腸 48 : 971-980, 2013
 
10) 岩渕三哉 : 内分泌細胞腫瘍. 病理と臨床 38 : 1018-1025, 2020
Medical*Online
11) Schlemper RJ, Riddell RH, Kato Y et al : The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47 : 251-255, 2000
PubMed
12) 遠城寺宗知, 渡辺英伸 : 消化管カルチノイドの病理学. 胃と腸 10 : 615-623, 1975
 
13) 岩渕三哉, 渡辺英伸, 野田裕他 : 腸カルチノイドの病理. 胃と腸 24 : 869-882, 1989
 
14) 渡辺英伸 : 腸のカルチノイド腫瘍-診断の問題点とトピックス (日米の比較を含む). 胃と腸 24 : 853-857, 1989
 
15) 岩下明徳, 山田豊, 八尾建史他 : 外科切除虫垂 2, 169例の臨床病理学的検索. 胃と腸 25 : 1185-1194, 1990
 
16) Iwafuchi M, Watanabe H, Ajioka Y et al : Immunohistochemical and ultrastructural studies of twelve argentaffin and six argyrophil carcinoids of the appendix vermiformis. Hum Pathol 21 : 773-780, 1990
PubMed
17) Iwafuchi M, Watanabe H, Nishikura K et al : Argentaffin carcinoid tumors of the rectum : an immunohistochemical and ultrastructural study. Acta Medica et Biologica 42 : 79-86, 1994
 
18) 岩渕三哉, 須貝美佳 : 大腸の神経内分泌腫瘍の病理. 杉原健一編 : 大腸疾患 NOW 2015, 日本メディカルセンター, 2015, pp61-75
 
19) 岩下明徳, 原岡誠司, 池田圭祐他 : 直腸カルチノイド腫瘍の臨床病理学的検索-転移例と非転移例の比較を中心に. 胃と腸 40 : 151-162
 
20) 河内洋, 小池盛雄 : 大腸カルチノイドおよび内分泌細胞癌-第62回大腸癌研究会アンケート結果を中心に. 武藤徹一郎監修, 渡辺英伸, 杉原健一, 多田正大編 : 大腸疾患 NOW, 日本メディカルセンター, 2006, pp179-185
 
21) 森脇義弘, 山崎安信, 須田嵩他 : 上行結腸原発内分泌細胞癌の1例. 日消誌96 : 1062-1066, 1999
 
22) 牧野浩司, 森山雄吉, 田中宣威他 : 高齢者の直腸内分泌細胞癌の1症例. 日消誌 96 : 1057-1061, 1999
Medical*Online
23) 岡田章一, 藤岡雅子, 田口誠一他 : きわめて予後不良であった直腸sm内分泌細胞癌の1例. 日消誌 99 : 282-288, 2002
Medical*Online
24) 岩渕三哉, 渡辺英伸, 石原法子他 : 消化管のカルチノイドと内分泌細胞癌の病理-その特徴と組織発生. 臨牀消化器内科 5 : 1669-1681, 1990
 
25) 須田武保, 畠山勝義, 酒井靖夫他 : 脳, 皮膚および縦隔に転移した直腸sm内分泌細胞癌の1例. 胃と腸 29 : 1302-1306, 1994
 
26) 岩渕三哉, 西倉健, 渡辺英伸 : 胃と腸の早期内分泌細胞癌-その特徴と発生. 消化器内視鏡 7 : 275-284, 1995
 
27) Nishikura K, Watanabe H, Iwafuchi M et al : Carcinogenesis of gastric endocrine cell carcinoma : analysis of histopathology and p53 gene alteration. Gastric Cancer 6 : 203-209, 2003
PubMed
28) 岩渕三哉, 渡邊徹, 池亀央嗣他 : 虫垂の内分泌細胞微小胞巣と微小カルチノイド腫瘍 : 形態的特徴と定義. ホルモンと臨床 50 (臨増) : 238-245, 2002
 
P.105 掲載の参考文献
1) Herxheimer G : Uber heterologe cancroid. Beitr Path Anat 41 : 348-412, 1907
 
2) Schmidtmann M : Zur Kenntnis seltener Krebsformen. Virchow Arch 226 : 100, 1919
 
3) Frizelle FA, Hobday KS, Batts KP et al : Adenosquamous and squamous carcinoma of the colon and upper rectum : a clinical and histopathologic study. Dis Colon Rectum 44 : 341-346, 2001
PubMed
4) 鈴木貴久, 鈴木孝, 篠田昌孝他 : 潰瘍性大腸炎に合併した大腸癌に扁平上皮癌巣を認めた1剖検例. 日消誌 104 : 684-689, 2007
 
5) 宇野浩司, 木田孝志, 大越祐一他 : 体液性高カルシウム血症を併発した上行結腸未分化癌の1例. 日消外会誌 38 : 1379-1383, 2005
 
6) 小沢俊文, 渡辺秀紀, 奥村浩二他 : 下行結腸に発生した腺扁平上皮癌の1例. Gastroenterol Endosc 48 : 43-50, 2006
 
7) 松井芳夫, 影山隆久 : リンパ節転移を伴った上行結腸腺扁平上皮癌の1例. 日消外会誌 44 : 596-602, 2011
 
8) Dong Y, Wang J, Ma H et al : Primary adenosquamous carcinoma of the colon : report of five cases. Surg Today 39 : 619-623, 2009
PubMed
P.107 掲載の参考文献
1) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
2) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours : Digestive System Tumours (5th ed.), IARC, Lyon, 2019
 
3) 遠山慎吾, 工藤克昌, 大沼忍他 : パクリタキセル+カルボプラチン療法が奏効したS状結腸未分化癌の1例. 癌と化学療法 43 : 2295-2297, 2016
Medical*Online
4) 西村洋治, 関根毅, 小林照忠他 : 稀な大腸悪性腫瘍の臨床病理学的検討. 第54回大腸癌研究会アンケート調査報告. 日本大腸肛門病会誌 57 : 132-140, 2004
 
5) 中崎隆行, 高木克典, 長谷場仁俊他 : 壁外発育型を呈した大腸未分化癌の1例. 日臨外会誌 66 : 1400-1403, 2005
 
P.110 掲載の参考文献
1) Murakami T, Yao T, Mitomi H et al : Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation : a study of 29 cases. Gastric Cancer 19 : 498-507, 2016
 
2) Akazawa Y, Saito T, Hayashi T et al : Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation : emphasis on the relationship with hepatoid adenocarcinoma. Hum Pathol 78 : 79-88, 2018
PubMed
3) Yatagai N, Saito T, Akazawa Y et al : TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation. Virchows 474 : 315-324, 2019
PubMed
4) Yatagai N, Saito T, Akazawa Y et al : Frequent loss of heterozygosity of SMAD4 locus and prognostic impacts of SMAD4 immunohistochemistry in gastric adenocarcinoma with enteroblastic differentiation. Hum Pathol 88 : 18-26, 2019
PubMed
5) Yamashiro Y, Saito T, Hayashi T et al : Molecular and clinicopathological features of colorectal adenocarcinoma with enteroblastic differentiation. Histopathology 77 : 492-502, 2020
PubMed
6) 沢田尭史, 本間重紀, 吉田雅他 : XELOX+bevacizumab療法が奏効しR0切除が得られたAFP産生大腸癌同時性肝転移の1例. 日外科系連会誌 43 : 845-854, 2018
 
7) 朝蔭直樹, 原口美明, 鈴木貴久他 : 急激な転帰をとったAFP産生S状結腸癌の1剖検例. 日消外会誌 107 : 1296-1304, 2010
 
8) Akiyama S, Tamura G, Endoh Y et al : Histogenesis of hepatoid adenocarcinoma of the stomach : molecular evidence of identical origin with coexistent tubular adenocarcinoma. Int J Cancer 106 : 510-515, 2003
PubMed
P.112 掲載の参考文献
1) Oh SK, Kim HW, Kang DH et al : Primary adenocarcinoma with focal choriocarcinomatous differentiation in the sigmoid colon. Korean J Gastroenterol 66 : 291-296, 2015
PubMed
2) Koelzer VH, Steuer K, Gross UC et al : Colorectal choriocarcinoma in a patient with probable Lynch syndrome. Front Oncol 6 : 252, 2016
 
3) 辻本武宏, 庄野嘉治, 石田興一郎他 : 多臓器転移をきたしたS状結腸原発絨毛癌の1例. 日臨外会誌 75 : 737-741, 2014
 
4) Lundin M, Nordling S, Carpelan-Holmstrom M et al : A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer. Anticancer Res 20 : 4949-4951, 2000
 
5) Kubosawa H, Nagao K, Kondo Y et al : Coexistence of adenocarcinoma and choriocarcinoma in the sigmoid colon. Cancer 54 : 866-868, 1984
PubMed
P.114 掲載の参考文献
1) Shepherd NA, Warren BF, Williams GT et al (eds) : Morson and Dawson's Gastrointestinal Pathology (5th ed.), Wiley-Blackwell, Hoboken, 2012, pp685-732
 
2) Matsusaka T, Watanabe H, Enjoji M : Pseudosarcoma and carcinosarcoma of the esophagus. Cancer 37 : 1546-1555, 1976
PubMed
3) Yamamoto Y, Watanabe Y, Horiuchi A et al : True carcinosarcoma of the esophagus : report of a case. Case Rep Gastroenterol 2 : 330-337, 2008
PubMed
4) Nagtegaal ID, Odze RD, Klimstra D et al : The 2019 WHO classification of tumours of the digestive system. Histopathology 76 : 182-188, 2020
PubMed
5) Mori Y, Katsumata K, Suzuki S et al : Carcinosarcoma of the sigmoid colon : report of a case. Case Rep Gastroenterol 4 : 484-491, 2010
PubMed
6) Conzo G, Giordano A, Candela G et al : Colonic carcinosarcoma. J Gastroenterol Hepatol 18 : 748-749, 2003
PubMed
7) Ambrosini-Spaltro A, Vaira V, Braidotti P et al : Carcinosarcoma of the colon : report of a case with morphological, ultrastructural and molecular analysis. BMC Cancer 6 : 185, 2006
PubMed
8) Sudlow A, Liu MH, Waters G et al : Carcinosarcoma of the rectum : report of a rare colorectal malignancy and review of the literature. Case Rep Surg. Article ID : 412918, doi : 10.1155/2015/412918, 2015
 
9) Shim HJ, Hong YK, Kim SJ et al : Carcinosarcoma on ascending colon found by bowel perforation : a case report. J Korean Soc Coloproctol 26 : 368-372, 2010
PubMed
10) Aramendi T, Fernandez-Acenero MJ, Villanueva MC : Carcinosarcoma of the colon : report of a rare tumor. Pathol Res Pract 199 : 345-348, 2003
PubMed
11) Weidner N, Zekan P : Carcinosarcoma of the colon. Report of a unique case with light and immunohistochemical studies. Cancer 58 : 1126-1130, 1986
PubMed
12) Roncaroli F, Montironi R, Feliciotti F et al : Sarcomatoid carcinoma of the anorectal junction with neuroendocrine and rhabdomyoblastic features. Am J Surg Pathol 19 : 217-223, 1995
 
13) Kolodziejczak M, Bielecki K, Sudol-Szopinska I et al : Very rare case of rectal carcinosarcoma. Tech Coloproctol 17 : 615-617, 2013
PubMed
14) Takeyoshi I, Yoshida M, Ohwada S et al : Skin metastasis from the spindle cell component in rectal carcinosarcoma. Hepatogastroenterology 47 : 1611-1614, 2000
PubMed
15) Ryu Y, Kim A, Kim H et al : Carcinosarcoma in the cecum. Gut Liver 6 : 395-398, 2012
PubMed
16) Chetty R, Bhathal PS : Caecal adenocarcinoma with rhabdoid phenotype : an immunohistochemical and ultrastructural analysis. Virchows Arch A Pathol Anat Histopathol 422 : 179-182, 1993
PubMed
17) Ishida H, Ohsawa T, Nakada H et al : Carcinosarcoma of the rectosigmoid colon : report of a case. Surg Today 33 : 545-549, 2003
PubMed
18) Choi YY, Jeen YM, Kim YJ : Sarcomatoid carcinoma of colon : extremely poor prognosis. J Korean Surg Soc 80 (Suppl 1) : S26-30, 2011
 
19) Keramidaris D, Koukoutsis I, Gourgiotis S et al : Sarcomatoid Carcinoma of the Anorectal Junction : Struggling with an Extremely Rare Tumor. J Gastrointest Cancer 43 (Suppl 1) : S93-96, 2012
 
20) Nakao A, Sakagami K, Uda M et al : Carcinosarcoma of the colon : report of a case and review of the literature. J Gastroenterol 33 : 276-279, 1998
PubMed
21) Isimbaldi G, Sironi M, Assi A : Sarcomatoid carcinoma of the colon. Report of the second case with immunohisto chemical study. Pathol Res Pract 192 : 483-487, 1996
 
22) Sandberg TP, Stuart MPME, Oosting J et al : Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer. BMC Cancer 19 : 284, 2019
 
23) Tanaka Y, Terai Y, Kawaguchi H et al : Prognostic impact of EMT (epithelial-mesenchymal-transition) -related protein expression in endometrial cancer. Cancer Biol Ther 14 : 13-19, 2013
PubMed
24) Sanchez-Tillo E, Lazaro A, Torrent R et al : ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene 29 : 3490-3500, 2010
PubMed
25) Moreno-Bueno G, Portillo F, Cano A : Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 27 : 6958-6969, 2008
PubMed
P.124 掲載の参考文献
1) Dei Tos AP, Hornick JL, Miettinen M : Gastrointestinal stromal tumour. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours : Digestive System Tumours" (5 th ed.), IARC, Lyon, 2019, pp439-443
 
2) Miettinen M, Lasota J : Gastrointestinal stromal tumors : pathology and prognosis at different sites. Semin Diagn Pathol 23 : 70-83, 2006
PubMed
3) Joensuu H : Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 39 : 1411-1419, 2008
PubMed
4) Fukayama M, Goldblum JR, Miettinen M et al (eds.) : Mesenchymal tumours of the digestive system. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours : Digestive System Tumours" (5 th ed.), IARC, Lyon, 2019, pp433-498
 
5) Yamamoto H, Handa M, Tobo T et al : Clinicopathological features of primary leiomyosarcoma of the gastrointestinal tract following recognition of gastrointestinal stromal tumours. Histopathology 63 : 194-207, 2013
PubMed
6) Yamamoto H : Inflammatory myofibroblastic tumour. in WHO Classification of Tumours Editorial Board (ed) : "WHO classification of Tumours : Soft Tissue and Bone Tumours" (5 th ed.), IARC, Lyon, 2020, pp109-111
 
7) 山元英崇, 小田義直 : 脱分化型脂肪肉腫-概念とその拡大-. 病理と臨床 34 : 595-599, 2016
Medical*Online
8) Gibson JA, Hornick JL : Mucosal Schwann cell "hamartoma" : clinicopathologic study of 26 neural colorectal polyps distinct from neurofibromas and mucosal neuromas. Am J Surg Pathol 33 : 781-787, 2009
PubMed
9) Groisman GM, Polak-Charcon S : Fibroblastic polyp of the colon and colonic perineurioma : 2 names for a single entity? Am J Surg Pathol 32 : 1088-1094, 2008
PubMed
10) Doyle LA, Hornick JL, Fletcher CD : PEComa of the gastrointestinal tract : clinicopathologic study of 35 cases with evaluation of prognostic parameters. Am J Surg Pathol 37 : 1769-1782, 2013
PubMed
P.135 掲載の参考文献
1) Swerdlow SH, Campo E, Harris NL et al (eds) : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (rev.4th ed.), IARC, Lyon, 2017
 
2) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours : Digestive System Tumours (5th ed.), IARC, Lyon, 2019
 
3) Sakugawa ST, Yoshino T, Nakamura S et al : API2-MALT1 fusion gene in colorectal lymphoma. Mod Pathol 16 : 1232-1241, 2003
PubMed
4) Falini B, Agostinelli C, Bigerna B et al : IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. Histopathology 61 : 930-941, 2012
PubMed
5) Yoshino, T, Miyake K, Ichimura K et al : Increased incidence of follicular lymphoma in the duodenum. Am J Surg Pathol 24 : 688-693, 2000
PubMed
6) Swerdlow SH, Campo E, Harris NL et al (eds) : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th ed.), IARC, Lyon, 2008
 
7) Yoshino T, Takata K, Tanaka T et al : Recent progress in follicular lymphoma in Japan and characteristics of the duodenal type. Pathol Int 68 : 665-676, 2018
PubMed
8) Takeuchi K, Yokoyama M, Ishizawa S et al : Lymphomatoid gastropathy : a distinct clinicopathologic entity of selflimited pseudomalignant NK-cell proliferation. Blood 116 : 5631-5637, 2010
PubMed
9) Mansoor A1, Pittaluga S, Beck PL et al : NK-cell enteropathy : a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma : clinicopathologic features and follow-up in a unique case series. Blood 117 : 1447-1452, 2011
 
P.144 掲載の参考文献
1) Utsunomiya J : The concept of hereditary colorectal cancer and implication of its study. in : Utsunomiya J, Lynch HT (eds) : Hereditary colorectal cancer, Springer Japan, Tokyo, 1990, pp3-16
 
2) 大腸癌研究会編 : 遺伝性大腸癌診療ガイドライン, 2020年版, 金原出版, 2020
 
3) 山口達郎 : 家族性大腸腺腫症 (FAP). 最新醫学 73 : 351-357, 2018
 
4) 田村和朗, 宇都宮譲二, 岩間毅夫他 : 家族性腺腫性ポリポーシスの二種類の責任遺伝子 : APCとMYH. 家族性腫瘍 4 : 85-92, 2004
Medical*Online
5) Tamura K, Utsunomiya J, Iwata T et al : Mechanism of carcinogenesis in familial tumors. Int J Clin Oncol 9 : 232-245, 2004
 
6) Kinzler KW, Nilbert MC, Su LK et al : Identification of FAP locus genes from chromosome 5q21. Science 253 : 661-665,1991
PubMed
7) Nishisho I, Nakamura Y, Miyoshi Y et al : Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253 : 665-669, 1991
PubMed
8) Schouten JP, McElgunn CJ, Waaijer R et al : Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30 : e57, 2002
PubMed
9) InSiGHT variants databases (https://www.insight-group.org/variants/databases/) [2021年3月閲覧]
 
10) 田村和朗, 宇都宮譲二, 岩間毅夫他 : hMYH-家族性腺腫性ポリポーシスの新しい責任遺伝子. 細胞 35 : 426-430, 2003
 
11) Jones S, Emmerson P, Maynard J et al : Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G : C → T : A mutations. Hum Mol Genet 11 : 2961-2967, 2002
 
12) Al-Tassan N, Chmiel NH, Maynanrd J et al : Inherited variants of MYH associated with somatic G : C → T : A mutations in colorectal tumors. Nat Genet 30 : 227-232, 2002
 
13) Lipton L, Halford SE, Johnson V et al : Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res 63 : 7595-7599, 2003
 
14) Middeldorp A, van Puijenbroek M, Nielsen M et al : Highfrequency of copy-neutral LOH in MUTYH-associated polyposis carcinomas. J pathol 216 : 25-31, 2008
 
15) Gomez-Fernandez N, Castellvi-Bel S, Fernandez-Rozadilla C et al : Molecular analysis of the APC and MUTYH genes in Galician and Catalonian FAP families : a different spectrum of mutations? BMC Med Genet 10, 2009, doi : 10.1186/1471-2350-10-57
 
16) Bisgaard ML, Ripa R, Kundsen AL et al : Familial adenomatous polyposis patients without an identified APC germline mutation have a severe phenotype. Gut 53 : 266-270, 2004
 
17) 田村和朗, 西脇学, 冨田尚裕 : 原因遺伝子の遺伝子診断と臨床像. 大腸癌 Frontier 3 : 109-114, 2010
Medical*Online
18) 冨田尚裕, 野田雅史, 松原長秀他 : 家族性大腸腺腫症. 外科 72 : 1321-1326, 2010
 
19) 杉田昭, 小金井一隆, 木村英明他 : 大腸全摘後再建術. 日外会誌 109 : 269-273, 2008
 
20) 飯合恒夫, 谷達夫, 丸山 聡他 : 大腸全摘術. 外科 70 : 61-66, 2008
 
21) 杉田昭, 小金井一隆, 山田恭子他 : 回腸嚢肛門吻合術, 回腸嚢肛門管吻合術. 外科治療 102 (増刊) : 594-601, 2010
Medical*Online
22) Bulow S, Bulow C, Vasen H et al : Colectomy and ileorectal anastomosis is still an option for selected patients with familial adenomatous polyposis. Dis Colon Rectum 51 : 1318-1323, 2008
PubMed
23) Kartheuser A, Stangherlin P, Brandt D et al : Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited. Fam Cancer 5 : 241-260, 2006
PubMed
24) Bertario L, Russo A, Radice P et al : Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis. Ann Surg 231 : 538-543, 2000
PubMed
25) Church J : In which patients do I perform IRA, and why? Fam Cancer 5 : 237-240, 2006
PubMed
26) 小山基, 森田隆幸, 村田暁彦他 : 家族性大腸腺腫症に対する結腸全摘・回腸直腸吻合術の長期術後成績. 日消外会誌 37 : 1509-1516, 2004
 
27) 小山基, 村田暁彦, 坂本義之他 : 家族性大腸腺腫症に対する予防的大腸手術の治療戦略. 家族性腫瘍 10 : 27-31, 2010
Medical*Online
28) 山村武平, 田村和朗, 荘司康嗣他 : 大腸全摘+回腸嚢肛門吻合術, 手術 45 : 1409-1416, 1991
 
29) Ueno H, Kobayashi H, Konishi T et al : Prevalence of laparoscopic surgical treatment and its clinical outcomes in patients with familial adenomatous polyposis in Japan. Int J Clin Oncol 21 : 713-722, 2016
PubMed
30) Gorgun E, Remzi FH, Goldberg JM et al : Fertility is reduced after restorative proctocolectomy with ileal pouch anal anastomosis : A study of 300 patients. Surgery 136 : 795-803, 2004
PubMed
31) Ault GT, Nunoo-Mensah JW, Johnson L et al : Adenocarcinoma arising in the middle of ileoanal pouches : report of five cases. Dis Colon Rectum 52 : 538-541, 2009
PubMed
32) Ishikawa H, Mutoh M, Iwama T et al : Endoscopic management of familial adenomatous polyposis in patients refusing colectomy. Endoscopy 48 : 51-55, 2016
PubMed
33) Iwama T, Tamura K, Morita T et al : A clinical overview of familial adenomatous polyposis derived from the database of the polyposis registry of Japan. Int J Clin Oncol 9 : 308-316, 2004
 
34) Vasen HFA, Moslein G, Alonso A et al : Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57 : 704-713, 2008
 
35) Guillem JG, Wood WC, Moley JF et al : ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. Ann Surg Oncol 13 : 1296-1321, 2006
PubMed
36) National Comprehensive Cancer Network : NCCN Clinical Practice Guidelines in Oncology : Genetic/Familial High-Risk Assessment : Colorectal. Version 2. 2019 (http://www.nccn.org) [2021年3月閲覧]
 
37) 冨田尚裕, 濱中美千子, 馬場谷彰仁他 : 家族性大腸腺腫症. 消化器内視鏡 30 : 1036-1042, 2018
Medical*Online
38) 冨田尚裕, 能浦真吾, 鈴木陽三他 : 消化器領域の遺伝性腫瘍 (家族性大腸腺腫症, リンチ症候群) の基礎知識. 消化器看護 25 : 82-91, 2020
 
39) 権藤延久 : 大腸ポリポーシス. 宇都宮譲二 監修, 恒松由記子編 : 家族性腫瘍遺伝カウンセリング-理論と実際-, 金原出版, 2000, pp254-261
 
P.149 掲載の参考文献
1) 大腸癌研究会編 : 遺伝性大腸癌診療ガイドライン, 2020年版, 金原出版, 2020
 
2) Nieuwenhuis MH, Bulow S, Bjork J et al : Genotype pre-dicting phenotype in familial adenomatous polyposis : a practical application to the choice of surgery. Dis Colon Rectum 52 : 1259-1263, 2009
 
3) Okamura T, Hashimoto T, Naka T et al : Clinicopathologic and molecular characteristics of familial adenomatous polyposis-associated traditional serrated adenoma. Am J Surg Pathol 44 : 1282-1289, 2020
PubMed
4) National Comprehensive Cancer Network : Genetic/familial high-risk assessment : colorectal (version 1.2020). (https://www.nccn.org/professionals/physician_gls/) [2021年3月閲覧]
 
5) Wu TT, Kornacki S, Rashid A et al : Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol 22 : 293-298, 1998
PubMed
6) 関根茂樹, 下田忠和, 中西幸浩他 : 家族性大腸腺腫症における胃底腺ポリープの腫瘍化. 胃と腸 39 : 1121-1126, 2004
 
7) Wood LD, Salaria SN, Cruise MW et al : Upper GI tract lesions in familial adenomatous polyposis (FAP) : enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms. Am J Surg Pathol 38 : 389-393, 2014
PubMed
8) Spigelman AD, Williams CB, Talbot IC et al : Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 2 : 783-785, 1989
PubMed
9) Saito Y, Hinoi T, Ueno H et al : Risk factors for the development of desmoid tumor after colectomy in patients with familial adenomatous polyposis : multicenter retrospective cohort study in Japan. Ann Surg Oncol 23 (Suppl 4) : 559-565, 2016
PubMed
10) Li J, Woods SL, Healey S et al : Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Hum Genet 98 : 830-842, 2016
PubMed
11) 関根茂樹 : 家族性大腸腺腫症とLynch症候群の診断の流れ. 病理と臨床 37 : 494-500, 2019
Medical*Online
P.156 掲載の参考文献
1) Lynch HT, Snyder CL, Shaw TG et al : Milestones of Lynch syndrome : 1895-2015. Nat Rev Cancer 15 : 181-194, 2015
PubMed
2) 大腸癌研究会編 : 遺伝性大腸癌診療ガイドライン, 2020年版, 金原出版, 2020
 
3) Umar A, Boland CR, Terdiman JP et al : Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96 : 261-268, 2004
PubMed
4) Vasen HF, Watson P, Mecklin JP et al : New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116 : 1453-1456, 1999
 
5) Niessen RC, Hofstra RM, Westers H et al : Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosomes Cancer. 48 : 737-744, 2009
PubMed
6) Gupta S, Provenzale D, Llor X et al : NCCN guidelines insights : genetic/familial high-risk assessment : colorectal, version 2.2019. J Natl Compr Canc Natw 17 : 1032-1041, 2019
 
7) Duraturo F, Liccardo R, De Rosa M et al : Genetics, diagnosis and treatment of Lynch syndrome : Old lessons and current challenges. Oncology Lett 17 : 3048-3054, 2019
 
8) Menahem B, Alves A, Regimbeau JM et al : Lynch syndrome : current management in 2019. J Visc Surg 156 : 507-514, 2019
PubMed
9) Ladabaum U, Ford JM, Martel M et al : American Gastroenterological Association technical review on the diagnosis and management of Lynch syndrome. Gastroenterology 149 : 783-813, 2015
PubMed
10) Rijcken FEM, Hollema H, Kleibeuker JH : Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut 50 : 382-386, 2002
 
11) Rondagh EJA, Gulikers S, Gomez-Garcia EB et al : Nonpolypoid colorectal neoplass. a challenge in endoscopic surveillance of patients with Lynch syndrome. Endoscopy 45 : 257-264, 2013
 
12) Inoki K, Nakajima T, Sekine S et al : Depressed-type submucosal invasive colorectal cancer in a patient with Lynch syndrome diagnosed using short-interval colonoscopy. Dig Endosc 28 : 749-754, 2016
 
13) Vleugels JLA, Sahin H, Hazewinkel Y et al : Endoscopic detection rate of sessile serrated lesions in Lynch syndrome patients is comparable with an age-and gendermatched control population : case-control study with expert pathology review. Gastrointest Endosc 87 : 1289-1296, 2018
 
14) Rivero-Sanchez L, Arnau-Collell C, Herrero J et al : White-light endoscopy is adequate for Lynch syndrome surveillance in a randomized and noninferiority study. Gastroenterology 158 : 895-904, 2020
 
15) Monahan K, Bradshaw N, Dolwani S et al : Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/association of coloproc tology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG). Gut 69 : 411-444, 2020
 
16) Rahmi G, Lecomte T, Malka D et al : Impact of chromoscopy on adenoma detection in patients with Lynch syndrome : a prospective, multicenter, blinded, tandem colonoscopy study. Am J Gastroenterol 110 : 288-298, 2015
PubMed
17) Cellier C, Perrod G, Colas C et al : Back-to-back comparison of colonoscopy with virtual chromoendoscopy using a third-generation narrow-band imaging system to chromoendoscopy with indigo carmine in patients with Lynch syndrome. Am J Gastroenterol 114 : 1665-1670, 2019
PubMed
18) Haanstra J, Dekker E, Cats A et al : Effect of chromoendoscopy in the proximal colon on colorectal neoplasia detection in Lynch syndrome : a multicenter randomized controlled trial. Gastrointest Endosc 90 : 624-632, 2019
PubMed
P.164 掲載の参考文献
1) 菅井有, 上杉憲幸, 幅野渉他 : 遺伝性非ポリポーシス大腸癌の臨床病理と分子異常-孤発性MSI陽性大腸癌との比較. 胃と腸 45 : 2065-2078, 2010
 
2) Gatalica Z, Torlakovic E : Pathology of the hereditary colorectal carcinoma. Fam Cancer 7 : 15-26, 2008
PubMed
3) Jass JR : HNPCC and sporadic MSI-H colorectal cancer : a review of the morphological similarities and differences. Fam Cancer 3 : 93-100, 2004
PubMed
4) Vasen HF, Mecklin JP, Khan PM et al : The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34 : 424-425, 1991
 
5) Boland CR, Goel A : Microsatellite instability in colorectal cancer. Gastroenterology 138 : 2073-2087, 2010
PubMed
6) Park JG, Vasen HF, Park KJ et al : Suspected hereditary nonpolyposis colorectal cancer : International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis. Dis Colon Rectum 42 : 710-715, 1999
 
7) Jass JR, Walsh MD, Barker M et al : Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability. Eur J Cancer 38 : 858-866, 2002
PubMed
8) Leggett B, Whitehall V : Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138 : 2088-2100, 2010
PubMed
9) 菅井有, 山野泰穂, 木村友昭他 : 腸管. 病理と臨床 28 (臨増) : 144-147, 2010
 
10) Jenkins MA, Hayashi S, O'Shea AM et al : Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability : a population-based study. Gastroenterology 133 : 48-56, 2007
 
11) Greenson JK, Huang SC, Herron C et al : Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol 33 : 126-133, 2009
PubMed
12) Michael-Robinson JM, Biemer-Huttmann A, Purdie DM et al : Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut 48 : 360-366, 2001
PubMed
13) Alexander J, Watanabe T, Wu TT et al : Histopathological identification of colon cancer with microsatellite instability. Am J Pathol 158 : 527-535, 2001
PubMed
14) Ward R, Meagher A, Tomlinson I et al : Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 48 : 821-829, 2001
PubMed
15) Smyrk TC, Watson P, Kaul K et al : Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer 91 : 2417-2422, 2001
PubMed
16) Greenson JK, Bonner JD, Ben-Yzhak O et al : Phenotype of microsatellite unstable colorectal carcinomas : well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol 27 : 563-570, 2003
PubMed
17) Pico MD, Castillejo A, Murcia O et al : Clinical and pathological characterization of Lynch-like syndrome. Clin Gastroenterol Hepatol 18 : 368-374, 2020
PubMed
18) Antelo M, Golubicki M, Roca E et al : Lynch-like syndrome is as frequent as Lynch syndrome in early-onset nonfamilial nonpolyposis colorectal cancer. Int J Cancer 145 : 705-713, 2019
PubMed
19) Weren RD, Ligtenberg MJ, Geurts van Kessel A et al : NTHL1 and MUTYH polyposis syndromes : two sides of the same coin? J Pathol 244 : 135-142, 2018
 
20) Heitzer E, Tomlinson I : Replicative DNA polymerase mutations in cancer. Curr Opin Genet Dev 24 : 107-113, 2014
PubMed
21) Briggs S, Tomlinson I : Germline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancers. J Pathol 230 : 148-153, 2013
 
22) Yamaguchi K, Shimizu E, Yamaguchi R et al : Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient. J Hum Genet 64 : 729-740, 2019
 
P.171 掲載の参考文献
1) Jeghers H, McKusick VA, Katz KH : Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits ; a syndrome of diagnostic significance. N Engl J Med 241 : 993, 1949
PubMed
2) Syngal S, Brand RE, Church JM et al : ACG clinical guideline : genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110 : 223-262, 2015
PubMed
3) Beggs AD, Latchford AR, Vasen HFA et al : Peutz-Jeghers syndrome : a systematic review and recommendations for management. Gut 59 : 975-986, 2010
 
4) Hinds R, Philp C, Hyer W et al : Complications of childhood Peutz-Jeghers syndrome : implications for pediatric screening. J Pediatr Gastroenterol Nutr 39 : 219-220, 2004
PubMed
5) Ohmiya N, Nakamura M, Takenaka H et al : Management of small-bowel polyps in Peutz-Jeghers syndrome by using enteroclysis, double-balloon enteroscopy, and videocapsule endoscopy. Gastrointest Endosc 72 : 1209-1216, 2010
PubMed
6) Veale AM, McColl I, Bussey HJ et al : Juvenile polyposis coli. J Med Genet 3 : 5-16, 1966
PubMed
7) 山本博徳, 阿部孝, 石黒信吾他 : 小児・成人のためのPeutz-Jeghers症候群診療ガイドライン (2020年版). 遺伝子腫瘍 20 : 59-78, 2020
 
8) Gallione C, Aylsworth AS, Beis J et al : Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome. Am J Med Genet A 152A : 333-339, 2010
 
9) Latchford AR, Neale K, Phillips RK et al : Juvenile polyposis syndrome : a study of genotype, phenotype, and longterm outcome. Dis Colon Rectum 55 : 1038-1043, 2012
 
10) Pilarski R, Burt R, Kohlman W et al : Cowden syndrome and the PTEN hamartoma tumor syndrome : systematic review and revised diagnostic criteria. J Natl Cancer Inst 105 : 1607-1616, 2013
PubMed
11) 高山哲治, 五十嵐正広, 大住省三他 : 小児・成人のためのCowden症候群/PTEN過誤腫症候群ガイドライン (2020年版). 遺伝子腫瘍 20 : 93-114, 2020
 
12) Pilarski R, Eng C : Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 41 : 323-326, 2004
PubMed
13) Pilarski R, Stephens JA, Noss R et al : Predicting PTEN mutations : an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features. J Med Genet 48 : 505-512, 2011
PubMed
14) Tan MH, Mester JL, Ngeow J et al : Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 18 : 400-407, 2012
PubMed
15) Heald B, Mester J, Rybicki L et al : Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology 139 : 1927-1933, 2010
 
16) Rosty C, Brosens LAA, Dekker E et al : Serrated polyposis. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumors : Digestive System Tumors" (5 th ed.), IARC, Lyon, 2019, pp532-534
 
17) Rodriguez-Alcalde D, Carballal S, Moreira L et al : High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome. Endoscopy 51 : 142-151, 2019
PubMed
18) Yan HHN, Lai JCW, Ho SL et al : RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation. Gut 66 : 1645-1656, 2017
PubMed
P.178 掲載の参考文献
1) 梅野淳嗣, 平野敦士, 藤岡審他 : ポリポーシス症候群の診断. 胃と腸 55 ; 730-744, 2020
 
2) Clouston AD, Walker NI : Polyps and tumour-like lesions of the large intestine. in Shepherd NA, Warren BF, Williams GT, et al (eds) : Morson and Dawson's Gastrointestinal Pathology (5th ed.), Wiley-Blackwell, Hoboken, 2013, pp668-672
 
3) Shepherd NA, Bussery HJ, JassJR : Epithelial misplacement in Peutz-Jeghers polyps. A diagnostic pitfall. Am J Surg Pathol 11 : 743-749, 1987
 
4) Jansen M, de Leng WW, Baas AF et al : Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis. Gut 55 : 1-5, 2006
PubMed
5) 太田玉紀, 渡辺英伸 : Peutz-Jeghers症候群と若年性ポリポーシス-病変の形態形成機序と腫瘍化. 胃と腸 28 : 1268-1278, 1993
 
6) 松本主之, 前畠裕司, 志方健太郎他 : 消化管ポリポーシスと癌化. 胃と腸 45 : 665-670, 2010
 
7) Giardiello FM, Welsh SB, Hamilton SR et al : Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316 : 1511-1514, 1987
PubMed
8) Hearle N, Schumacher V, Menko FH et al : Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12 : 3209-3215, 2006
PubMed
9) van Lier MG, Wagnar A, Mathus-Vliegen EM et al : High cancer risk in Peutz-Jeghers syndrome : a systematic review and surveillance recommendations. Am J Gastroenterol 105 : 1258-1264, 2010
 
10) Jarvinen HJ, Sipponen P : Gastroduodenal polyps in familial adenomatous and juvenile polyposis. Endoscopy 18 : 230-234, 1986
PubMed
11) Offerhaus GJA, Brosens LAA, Jansen M : Polyps and tumour-like lesions of the small intestine. in Shepherd NA, Warren BF, Williams GT, et al (eds) : "Morson and Dawson's Gastrointestinal Pathology" (5 th ed.), Wiley-Blackwell, Hoboken, 2013, pp415-418
 
12) Nakamura SI, Kino I, Akagi T : Inflammatory myoglandular polyps of the colon and rectum. A clinicopathological study of 32 pedunculated polyps, distinct from other types of polyps. Am J Pathol 16 : 772-779, 1992
 
13) Jass JR, Williams CB, Bussey HJ et al : Juvenile polyposis-a precancerous condition. Histopathology 13 : 619-630, 1988
PubMed
14) Lashner BA, Riddell RH, Winans CS : Ganglioneuromatosis of the colon and extensive glycogenic acanthosis in Cowden's disease. Dig Dis Sci 31 : 213-216, 1986
 
15) Hizawa K, Ikeda M, Matsumoto T et al : Gastrointestinal manifestations of Cowden's disease. Report of four cases. J Clin Gastroenterol 18 : 13-18, 1994
 
16) 菅井有 : 腸管-腫瘍性疾患-. ポリポーシス (家族性腫瘍も含む) と孤発性ポリープ. 深山正久, 森永正二郎編 : 外科病理学, 第5版, 文光堂, 2020, pp582-585
 
17) Williams GT, Bussey HJR, Morson BC : Inflammatory "cap" polyps of the large intestine. Br J Surg 72 (Suppl) : S133, 1985
 
18) Campbell AP, Cobb CA, Chapman RW et al : Cap polyposis-an unusual cause of diarrhoea. Gut 34 : 562-564, 1993
PubMed
19) 八尾隆史 : 腸管-非腫瘍性疾患-. cap polyposis. 深山正久, 森永正二郎編 : 外科病理学, 第5版, 文光堂, 2020, p552
 
20) 赤松泰次 : cap polyposis. 胃と腸 48 : 1192-1193, 2013
 
21) Akamatsu T, Nakamura N, Kawamura Y et al : Possible relationship between Helicobacter pylori infection and cap polyposis of the colon. Helicobacter 9 : 651-656, 2004
PubMed
22) 八尾隆史, 江崎幹宏, 古賀秀樹他 : cap polyposisの病理組織学的特徴-粘膜脱症候群との比較. 胃と腸 37 : 631-639, 2002
 
P.185 掲載の参考文献
1) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
2) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours : Digestive System Tumours (5th ed.), IARC, Lyon, 2019
 
3) Jass JR, Baker K, Zlobec I et al : Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas : concept of a 'fusion' pathway to colorectal cancer. Histopathology 49 : 121-131, 2006
PubMed
4) O'Brien MJ, Yang S, Mack C et al : Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30 : 1491-1501, 2006
 
5) Spring KJ, Zhao ZZ, Karamatic R et al : High prevalence of sessile serrated adenomas with BRAF mutations : a prospective study of patients undergoing colonoscopy. Gastroenterology 131 : 1400-1407, 2006
PubMed
6) Carr NJ, Mahajan H, Tan KL et al : Serrated and non-serrated polyps of the colorectum : their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 62 : 516-518, 2009
 
7) 広岡大司, 中村真一, 喜納勇他 : 背景粘膜にびまん性過形成性結節を伴った多発大腸癌の1例. 胃と腸 15 : 987-994, 1980
 
8) Shepherd NA, Warren BF, Williams GT et al : Morson and Dawson's Gastrointestinal Pathology (5th ed.), Wiley-Blackwell, Hoboken, 2013
 
9) Koga H, Iida M, Aoyagi K et al : Generalized giant inflammatory polyposis in a patient with ulcerative colitis presenting with protein-losing enteropathy. Am J Gastroenterol 90 : 829-831, 1995
 
10) Yada S, Matsumoto T, Kudo T et al : Colonic obstruction due to giant inflammatory polyposis in a patient with ulcerative colitis. J Gastroenterol 40 : 536-539, 2005
 
11) Nakamura S, Kino I, Akagi T : Inflammatory myoglandular polyps of the colon and rectum. A clinicopathological study of 32 pedunculated polyps, distinct from other types of polyps. Am J Surg Pathol 16 ; 772-779, 1992
PubMed
12) 菅井 有, 上杉憲幸, 杉本亮 : inflammatory myoglandular polypと若年性ポリープの病理学的鑑別-inflammatory myoglandular polypの臨床病理学的特徴. 胃と腸 48 : 1161-1174, 2013
 
13) 渡辺英伸, 味岡洋一, 田口夕美子他 : 直腸の粘膜脱症候群 (mucosal prolapse syndrome) の病理形態学的検討. 胃と腸 22 : 303-312, 1987
 
14) 八尾隆史, 江崎幹宏, 古賀秀樹他 : cap polyposisの病理組織学的特徴-粘膜脱症候群との比較. 胃と腸 37 : 631-639, 2002
 
15) Matake H, Matsui T, Yao T et al : Long pedunculated colonic polyp composed of mucosa and submucosa : proposal of a new entity, colonic muco-submucosal elongated polyp. Dis Colon Rectum 41 : 1557-1561, 1998
PubMed
16) Tozawa K, Ohda Y, Matsumoto T et al : Clinical challenges and images in GI. Colonic mucosubmucosal elongated polyp. Gastroenterology 136 : 49, 366, 2009
 
17) Alizart MM, Rosty C, Brown IS : Colonic mucosubmucosal elongated polyp : a clinicopathologic study of 13 cases and review of the literature. Am J Surg Pathol 35 : 1818-1822, 2011
PubMed
18) Gagliardi G, Thompson IW, Hershman MJ et al : Pneumatosis coli : a proposed pathogenesis based on study of 25 cases and review of the literature. Int J Colorectal Dis 11 : 111-118, 1996
 
19) 齋藤大祐, 林田真理, 三浦みき他 : 腸管嚢胞様気腫症の臨床的検討. 日消誌 112 : 494-499, 2015
Medical*Online
20) Iacopini F, Gotoda T, Elisei W et al : Heterotopic gastric mucosa in the anus and rectum : first case report of endoscopic submucosal dissection and systematic review. Gastroenterol Rep 4 : 196-205, 2016
PubMed
21) Morson BC : Colour Atlas of Gastrointestinal Pathology, Oxford University Press, Oxford, 1988, p277
 
22) 宗本義則, 海崎泰治, 林田有一他 : 集簇性の乳頭状隆起を呈した腸管子宮内膜症の1例. 胃と腸 40 : 239-244, 2005
 
23) 太田恭弘, 渕上忠彦, 堺勇二他 : 直腸内に発育し扁平上皮癌を合併した尖圭コンジローマの1例. 胃と腸 38 : 1315-1320, 2003
 
24) 高橋雅恵, 堀口慎一郎, 山澤翔他 : 肛門部尖圭コンジローマおよび高異型度肛門上皮内腫瘍の並存例 ; ヒトパピローマウイルスDNAの局在解析を含め. 診断病理 32 : 136-140, 2015
Medical*Online
25) Liu TC, Lin MT, Montgomery EA et al : Inflammatory fibroid polyps of the gastrointestinal tract : spectrum of clinical, morphologic, and immunohistochemistry features. Am J Surg Pathol 37 : 586-592, 2013
PubMed
26) Sugawara T, Sugita S, Tateno M et al : Colonic inflammatory fibroid polyp with PDGFRA expression. Pathol Int 68 : 205-206, 2018
PubMed
27) 山根建樹, 加藤弘之, 中村 眞他 : 特異な形態を呈し出血をきたした大腸アミロイドーシスの1例. 日消誌 98 : 533-537, 2001
Medical*Online
28) 野田久嗣, 小笠原尚高, 伊藤義紹他 : 粘膜下腫瘍様形態を呈した直腸孤立型アミロイドーシスの1例. 胃と腸 49 : 359-364, 2014
 
29) Goldblum JR, Beals T, Weiss SW : Elastofibromatous change of the rectum. A lesion mimicking amyloidosis. Am J Surg Pathol 16 : 793-795, 1992
PubMed
30) Ishida M, Iwai M, Kagoteni A et al : Elastofibromatous change of the intestine : report of four lesions from three patients with review of the literature. Int J Clin Exp Pathol 15 : 2291-2297, 2014
 
P.195 掲載の参考文献
1) Dulai PS, Sandborn WJ, Gupta S : Colorectal cancer and dysplasia in inflammatory bowel disease : a review of disease epidemiology, pathophysiology, and management. Cancer Prev Res (Phila) 9 : 887-894, 2016
PubMed
2) Eaden JA, Abrams KR, Mayberry JF : The risk of colorectal cancer in ulcerative colitis : a meta-analysis. Gut 48 : 526-535, 2001
PubMed
3) Zisman TL, Rubin DT : Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol 14 : 2662-2669, 2008
PubMed
4) 八尾隆史 : 症例診断の解説とまとめ. 胃と腸 54 : 1509-1526, 2019
 
5) Odze RD, Harpaz N : Inflammatory bowel disease-associated dysplasia of the colorectum. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours : Digestive System Tumours" (5 th ed.), IARC, Lyon, 2019, pp174-176
 
6) 林宏行, 小金井一隆 : 潰瘍性大腸炎関連腫瘍に対する内視鏡治療-私はこう考える. 胃と腸 55 : 180-182, 2020
 
7) 林宏行, 小野響子, 杉田昭他 : 潰瘍性大腸炎における異形成/癌の診断基準と問題点. 胃と腸 54 : 1502-1508, 2019
 
8) Watanabe T, Ajioka Y, Mitsuyama K et al : Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer. Gastroenterology 151 : 1122-1130, 2016
PubMed
9) 清水誠治, 富岡秀夫, 小木曽聖他 : EUSが診断の契機となった潰瘍性大腸炎関連大腸癌の1例. 55 : 201-207, 2020
 
10) 杉田昭, 小金井一隆, 辰巳健志他 : クローン病に合併する直腸肛門管癌. 日消誌 110 : 396-402, 2013
Medical*Online
11) De Jong ME, Van Tilburg SB, Nissen LHC et al : Longterm risk of advanced neoplasia after colonic low-grade dysplasia in patients with inflammatory bowel disease : a nationwide cohort study. J Crohns Colitis 13 : 1485-1491, 2019
 
12) Riddell RH, Goldman H, Ransohoff DE et al : Dysplasia in inflammatory bowel disease : standardized classification with provisional clinical applications. Hum Pathol 14 : 931-968, 1983
 
13) 武藤徹一郎, 若狭治毅, 喜納 勇他 : 潰瘍性大腸炎に出現する異型上皮の病理組織学的判定基準-surveillance colonoscopyへの応用を目的とした新判定基準の提案. 日本大腸肛門病会誌 47 : 547-551, 1994
 
14) 味岡洋一, 谷優佑 : 潰瘍性大腸炎に出現する異型上皮の厚労省研究班分類. 胃と腸 54 : 714-715, 2019
 
15) 味岡洋一 : 潰瘍性大腸炎における腫瘍性病変の診断-特に生検診断-. 病理と臨床 23 : 843-851, 2005
Medical*Online
16) Harpaz N, Polydorides AD : Colorectal dysplasia in chronic inflammatory bowel disease : pathology, clinical implications, and pathogenesis. Arch Pathol Lab Med 134 : 876-895, 2010
PubMed
17) Burmer GC, Rabinovitch PS, Haggitt RC et al : Neoplastic progression in ulcerative colitis : histology, DNA content, and loss of a p53 allele. Gastroenterology 103 : 1602-1610, 1992
PubMed
18) Robles AI, Traverso G, Zhang M et al : Whole-exome sequencing analyses of inflammatory bowel disease-associated colorectal cancers. Gastroenterology 150 : 931-943, 2016
PubMed
19) Iwaya M, Ota H, Tateishi Y et al : Colitis-associated colorectal adenocarcinomas are frequently associated with non-intestinal mucin profiles and loss of SATB2 expression. Mod Pathol 32 : 884-892, 2019
PubMed
20) Borralho P, Vieira A, Freitas J et al : Aberrant gastric apomucin expression in ulcerative colitis and associated neoplasia. J Crohns Colitis 1 : 35-40, 2007
 
21) 田中正則 : 通常腺腫とcolitic cancer/dysplasiaの鑑別-生検を含む. 胃と腸 37 : 971-979, 2002
 
22) Yaeger R, Shah MA, Miller VA et al : Genomic alterations observed in colitis-associated cancers are distinct from those found in sporadic colorectal cancers and vary by type of inflammatory bowel disease. Gastroenterology 151 : 278-287, 2016
PubMed
23) Choi CR, Bakir IA, Hart AL et al : Clonal evolution of colorectal cancer in IBD. Nat Rev Gastroenterol Hepatol 14 : 218-229, 2017
PubMed
24) Kobayashi S, Fujimori T, Mitomi H et al : Immunohistochemical assessment of a unique basal pattern of p53 expression in ulcerative-colitis-associated neoplasia using computer-assisted cytometry. Diagn Pathol 9 : 99, 2014
PubMed
25) Kinoshita S, Uraoka T, Nishizawa T et al : The role of colorectal endoscopic submucosal dissection in patients with ulcerative colitis. Gastrointest Endosc 87 : 1079-1084, 2018
PubMed
26) 松井啓, 早坂淳之介, 山下聡他 : 潰瘍性大腸炎関連腫瘍に対する内視鏡治療の適応とピットフォール. 胃と腸 55 : 159-166, 2020
 
27) Hayashi H, Miyagi Y, Sekiyama A et al : Colorectal small cell carcinoma in ulcerative colitis with identical rare p53 gene mutation to associated adenocarcinoma and dysplasia. J Crohns Colitis 6 : 112-115, 2012
PubMed
28) Yoshihara T, Shinzaki S, Hiyama S et al : Metastatic colon neuroendocrine carcinoma found in a patient with ulcerative colitis during annual endoscopic surveillance. Gastrointest Endosc 84 : 1075-1076, 2016
 
29) Kanada S, Sugita A, Mikami T et al : Microcarcinoid arising in patients with long standing ulcerative colitis : histological analysis. Hum Pathol 64 : 28-36, 2017
PubMed
P.203 掲載の参考文献
1) Islami F, Ferlay J, Lortet-Tieulent J et al : International trends in anal cancer incidence rates. Int J Epidemiol 46 : 924-938, 2017
PubMed
2) 鮫島伸一, 澤田俊夫, 長廻紘 : 本邦における肛門扁平上皮癌, 痔瘻癌の現況, 第59回大腸癌研究会アンケート調査報告. 日本大腸肛門病会誌 58 : 415-421, 2005
 
3) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
4) Brierley JD, Gospodarowics MK, Wittekind C (eds) : TNM Classification of Malignant Tumours (8th ed.), Wiley-Blackwell Hoboken, 2017
 
5) Kodama M, Kobayashi D, Iihara K et al : Adenocarcinoma within anorectal fistulae : different clinicopathological characteristics between Crohn's disease-associated type and the usual type. Mod Pathol 32 : 314-325, 2019
PubMed
6) 佐藤太一, 山田一隆, 緒方俊二他 : 痔瘻癌25例の臨床病理学的検討. 日消外会誌 49 : 579-587, 2016
 
7) Nishigami T, Kataoka TR, Ikeuchi H et al : Adenocarcinomas associated with perianal fistulae in Crohn's disease have a rectal, not an anal, immunophenotype. Pathology 43 : 36-39, 2011
 
8) Goldblum JR, Klimstra DS, Lam AK (eds.) : Tumours of the anal canal. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours : Digestive System Tumours" (5 th ed.), IARC, Lyon, 2019, pp193-212
 
9) Sun G, Dong X, Tang X et al : The prognostic value of HPV combined p16 status in patients with anal squamous cell carcinoma : a meta-analysis. Oncotarget 9 : 8081-8088, 2017
PubMed
10) Rodel F, Wieland U, Fraunholz I et al : Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy. Int J Cancer 136 : 278-288, 2015
PubMed
11) Patil DT, Goldblum JR, Billings SD : Clinicopathological analysis of basal cell carcinoma of the anal region and its distinction from basaloid squamous cell carcinoma. Mod Pathol 26 : 1382-1389, 2013
PubMed
12) 姚思遠, 橋田裕毅, 貝原聡他 : Paget現象との鑑別が困難であった肛門周囲Paget病の1例. 日臨外会誌 74 : 3430-3434, 2013
 
13) Singer M, Mutch MG. Anal melanoma : Clin Colon Rectal Surg 19 : 78-87, 2006
 
P.206 掲載の参考文献
1) 原岡誠司 : 転移性腫瘍. 八尾隆史, 藤盛隆博編 : 腫瘍病理鑑別診断アトラス 大腸癌, 文光堂, 2011, pp172-181
 
2) 中英男, 本告 匡, 岡慎一郎他 : 剖検例における消化管転移性癌の臨床病理学的研究. 北里医学 19 : 254-257, 1989
 
3) 石川勉, 縄野繁, 水口安則他 : 転移性大腸癌の形態診断-X線像の解析を中心に-. 胃と腸 23 : 617-630, 1988
 
4) 順天堂大学医学部病理学第一講座編 : 福田芳郎教授退官記念研究業績集, 福田芳郎教授退官記念会, pp228-245, 1991
 
5) Schirmacher P : Digestive system metastases. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours : Digestive System Tumours" (5th ed.), IARC, Lyon, 2019, pp506-509
 

第3部 病理診断の実際

P.214 掲載の参考文献
1) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
2) 江頭由太郎, 芥川寛 : 組織学的マクロ再構築図 (いわゆるマッピング図) の作り方. 胃と腸 51 : 1185-1196, 2016
 
3) Yamamoto H, Imai K : Microsatellite instability : an update. Arch Toxicol 89 : 899-921, 2015
PubMed
4) 関根茂樹 : 大腸. 病理と臨床 38 (臨増) : 107-112, 2020
 
5) 日本臨床腫瘍学会編 : 大腸がん診療における遺伝子関連検査のガイダンス, 第3版, 金原出版, 2016
 
6) 桑田健 : MMR異常の免疫組織化学的検出. 病理と臨床 38 (臨増) : 392-396, 2020
 
7) 西原広史 : クリニカルシークエンスにおける病理診断医の役割. 病理と臨床 36 : 660-665, 2018
Medical*Online
8) Louis DN, Ohgaki H, Wiestler OD et al (eds) : WHO Classification of Tumours of the Central Nervous System, (rev. 4th ed.), IARC, Lyon, 2016
 
P.220 掲載の参考文献
1) Sugai T, Uesugi N, Kitada Y et al : Analysis of the expression of cancer-associated fibroblast-and EMT-related proteins in submucosal invasive colorectal cancer. J Cancer 9 : 2702-2712, 2018
PubMed
2) 菅井有 : desmoplasia. 胃と腸 52 (増刊) : 703, 2017
 
3) Hirose M, Fukui H, Igarashi Y et al : Detection of desmoplastic reaction in biopsy specimens is useful for predicting the depth of invasion of early colorectal cancer : a Japanese collaborative study. J Gastroenterol 45 : 1212-1218, 2010
PubMed
4) Kimura R, Fujimori T, Ichikawa K et al : Desmoplastic reaction in biopsy specimens of early colorectal cancer : a Japanese prospective multicenter study. Pathol Int 62 : 525-531, 2012
PubMed
5) Ohno K, Fujimori T, Okamoto Y et al : Diagnosis of desmoplastic reaction by immunohistochemical analysis, in biopsy specimens of early colorectal carcinomas, is efficacious in estimating the depth of invasion. Int J Mol Sci 14 : 13129-13136, 2013
PubMed
6) Ueno H, Shinto E, Shimazaki H et al : Histologic categorization of desmoplastic reaction : its relevance to the colorectal cancer microenvironment and prognosis. Ann Surg Oncol 22 : 1504-1512, 2015
 
P.230 掲載の参考文献
1) 今井環 : 人体癌腫発育状況の形態学的考察. 福岡医誌 45 : 72-102, 1954
 
2) Morodomi T, Isomoto H, Shirouzu K et al : An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 63 : 539-543, 1989
PubMed
3) Hase K, Shatney C, Johnson D et al : Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum 36 : 627-635, 1993
PubMed
4) Ueno H, Murphy J, Jass JR et al : Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40 : 127-132, 2002
PubMed
5) Ueno H, Mochizuki H, Hashiguchi Y et al : Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 127 : 385-394, 2004
PubMed
6) Kawachi H, Eishi Y, Ueno H et al : A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer : A retrospective multicenter study. Mod Pathol 28 : 872-879, 2015
PubMed
7) Lugli A, Kirsch R, Ajioka Y et al : Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol 30 : 1299-1311, 2017
PubMed
8) Ueno H, Ishiguro M, Nakatani E et al : Prospective multicenter study on the prognostic and predictive impact of tumor budding in Stage II colon cancer : results from the SACURA trial. J Clin Oncol 37 : 1886-1894, 2019
 
9) Zlobec I, Lugli A : Tumour budding in colorectal cancer : molecular rationale for clinical translation. Nat Rev Cancer 18 : 203-204, 2018
PubMed
10) Grigore AD, Jolly MK, Jia D et al : Tumor budding : the name is EMT. Partial EMT. J Clin Med 5 : 51, 2016
 
11) Yamada N, Sugai T, Eizuka M et al : Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition. Hum Pathol 60 : 151-159, 2017
PubMed
12) Ueno H, Kajiwara Y, Shimazaki H et al : New criteria for histologic grading of colorectal cancer. Am J Surg Pathol 36 : 193-201, 2012
PubMed
13) Ueno H, Hase K, Hashiguchi Y et al : Site-specific tumor grading system in colorectal cancer : multicenter pathologic review of the value of quantifying poorly differentiated clusters. Am J Surg Pathol 38 : 197-204, 2014
PubMed
14) Ueno H, Hashiguchi Y, Kajiwara Y et al : Proposed objective criteria for "Grade 3" in early invasive colorectal cancer. Am J Clin Pathol 134 : 312-322, 2010
PubMed
15) Ueno H, Hase K, Hashiguchi Y et al : Novel risk factors for lymph node metastasis in early invasive colorectal cancer : a multi-institution pathology review. J Gastroenterol 49 : 1314-1323, 2014
PubMed
16) Ueno H, Shinto E, Kajiwara Y et al : Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer. Br J Cancer 111 : 2082-2090, 2014
PubMed
17) Ryan E, Khaw YL, Creavin B et al : Tumor budding and PDC grade are stage independent predictors of clinical outcome in mismatch repair deficient colorectal cancer. Am J Surg Pathol 42 : 60-68, 2018
PubMed
18) Konishi T, Shimada Y, Lee LH et al : Poorly differentiated clusters predict colon cancer recurrence : an in-depth comparative analysis of invasive-front prognostic Markers. Am J Surg Pathol 42 : 705-714, 2018
 
19) Yonemura K, Kajiwara Y, Ao T et al : Prognostic Value of Poorly Differentiated Clusters in Liver Metastatic Lesions of Colorectal Carcinoma. Am J Surg Pathol 43 : 1341-1348, 2019
PubMed
20) Kinoshita O, Kishimoto M, Murayama Y et al : The number of metastatic lymph nodes exhibiting poorly differentiated clusters predicts sur vival in patients with pStage III colorectal cancer. Int J Colorectal Dis 31 : 283-290, 2016
 
21) Shivji S, Conner JR, Barresi V et al : Poorly differentiated clusters in colorectal cancer : A current review and implications for future practice. Histopathology 77 : 351-368, 2020
PubMed
22) Shirouzu K, Isomoto H, Kakegawa T : Prognostic evaluation of perineural invasion in rectal cancer. Am J Surg 165 : 233-237, 1993
PubMed
23) Liebig C, Ayala G, Wilks JA, et al : Perineural invasion in cancer : a review of the literature. Cancer 115 : 3379-3391, 2009
 
24) Liebig C, Ayala G, Wilks J et al : Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol 27 : 5131-5137, 2009
PubMed
25) Ueno H, Shirouzu K, Eishi Y et al : Characterization of perineural invasion as a component of colorectal cancer staging. Am J Surg Pathol 37 : 1542-1549, 2013
PubMed
26) Ueno H, Shirouzu K, Shimazaki H et al : Histogenesis and prognostic value of myenteric spread in colorectal cancer : a Japanese multi-institutional study. J Gastroenterol 49 : 400-407, 2014
PubMed
27) Ueno H, Mochizuki H, Shirouzu K et al : Actual status of distribution and prognostic impact of extramural discontinuous cancer spread in colorectal cancer. J Clin Oncol 29 : 2550-2556, 2011
PubMed
28) Nagtegaal ID, Quirke P : Colorectal tumour deposits in the mesorectum and pericolon ; a critical review. Histopathology 51 : 141-149, 2007
PubMed
29) Ueno H, Mochizuki H, Hashiguchi Y et al : Extramural cancer deposits without nodal stracture in colorectal cancer : optimal categorization for prognostic staging. Am J Clin Pathol 127 : 287-294, 2007
 
30) Quirke P, Cuvelier C, Ensari A et al : Evidence-based medicine : the time has come to set standards for staging. J Pathol 221 : 357-360, 2010
PubMed
31) Ueno H, Mochizuki H, Shirouzu K et al : Multicenter study for optimal categorization of extramural tumor deposits for colorectal cancer staging. Ann Surg 255 : 739-746, 2012
PubMed
32) Ueno H, Mochizuki H, Akagi Y et al : Optimal colorectal cancer staging criteria in TNM classification. J Clin Oncol 30 : 1519-1526, 2012
PubMed
33) Nagtegaal ID, Knijn N, Hugen N et al : Tumor deposits in colorectal cancer : improving the value of modern staging-a systematic review and meta-analysis. J Clin Oncol 35 : 1119-1127, 2017
PubMed
34) Mueller MM, Fusenig NE : Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4 : 839-849, 2004
PubMed
35) Ueno H, Jones AM, Wilkinson KH et al : Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut 53 : 581-586, 2004
PubMed
36) Ueno H, Konishi T, Ishikawa Y et al : Histologic categorization of fibrotic cancer stroma in the primary tumor is an independent prognostic index in resectable colorectal liver metastasis. Am J Surg Pathol 38 : 1380-1386, 2014
PubMed
37) Ueno H, Kanemitsu Y, Sekine S et al : Desmoplastic pattern at the tumor front defines poor-prognosis subtypes of colorectal cancer. Am J Surg Pathol 41 : 1506-1512, 2017
PubMed
38) Ueno H, Kanemitsu Y, Sekine S et al : A multicenter study of the prognostic value of desmoplastic reaction categorization in stage II colorectal cancer. Am J Surg Pathol 43 : 1015-1022, 2019
PubMed
39) Nearchou IP, Kajiwara Y, Mochizuki S et al : Novel internationally verified method reports desmoplastic reaction as the most significant prognostic feature for disease-specific survival in stage II colorectal cancer. Am J Surg Pathol 43 : 1239-1248, 2019
PubMed
40) Ueno H, Jones A, Jass JR et al : Clinicopathological significance of the 'keloid-like' collagen and myxoid stroma in advanced rectal cancer. Histopathology 40 : 327-334, 2002
PubMed
P.237 掲載の参考文献
1) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
2) 日本胃癌学会編 : 胃癌取扱い規約, 第15版, 金原出版, 2017
 
3) Hashimoto T, Tanaka Y, Ogawa R et al : Superficially serrated adenoma : a proposal for a novel subtype of colorectal serrated lesion. Mod Pathol 31 : 1588-1598, 2018
PubMed
4) Bettington M, Walker N, Rosty C et al : Serrated tubulovillous adenoma of the large intestine. Histopathology 68 : 578-587, 2016
PubMed
5) 八尾隆史 : 大腸腫瘍の病理診断の課題と将来展望, 症例診断の解説とまとめ. 胃と腸 54 : 1509-1526, 2019
 
6) Talbot I, Price A, Salto-Tellez M (eds) : Biopsy Pathology in Colorectal Disease (2nd ed.), Hodder Arnold, London, 2007
 
7) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours : Digestive System Tumours (5th ed.), IARC, Lyon, 2019
 
8) Kamaradova K, Volmikova H, Rozkolova K et al : Nonconventional mucosal lesions (serrated epithelial change, villous hypermucinous change) are frequent in patients with inflammatory bowel disease-results of molecular and immunohistochemical single institutional study. Virchows Arch 476 : 231-241, 2020
 
9) Levi GS, Harpaz N : Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease. Am J Surg Pathol 30 : 1022-1029, 2006
PubMed
10) Miettinen, M Sarlomo-Rikala, M Sobin, LH : Mesenchymal tumors of muscularis mucosae of colon and rectum are benign leiomyomas that should be separated from gastrointestinal stromal tumors-a clinicopathologic and immunohistochemical study of eighty-eight cases. Mod Pathol 14 : 950-956, 2001
PubMed
P.246 掲載の参考文献
1) 大腸癌研究会編 : 大腸癌治療ガイドライン 医師用 2019年版, 金原出版, 2019 (http://www.jsccr.jp/guideline/2019/index_guide.html) [2021年3月閲覧]
 
2) Ueno H, Kajiwara Y, Shimazaki H et al : New criteria for histologic grading of colorectal cancer. Am J Surg Pathol 36 : 193-201, 2012
PubMed
3) Barresi V, Bonetti LR, Branca G et al : Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading. Virchows Arch 461 : 621-628, 2012
 
4) 上野秀樹, 神藤英二, 島崎英幸他 : 大腸T1 (SM) 癌における簇出・低分化胞巣の臨床的意義. 胃と腸 49 : 1057-1062, 2014
 
5) Kinoshita O, Kishimoto M, Murayama Y et al : Poorly differentiated clusters with larger extents have a greater impact on survival : a semi-quantitative pathological evaluation for 239 patients with non-mucinous pT2-3 colorectal carcinoma. World J Surgi Oncol 13 : 140, 2015
 
6) Ueno H, Hase K, Hashiguchi Y et al : Site-specific tumor grading system in colorectal cancer : multicenter pathologic review of the value of quantifying poorly differentiated clusters. Am J Surg Pathol 38 : 197-204, 2014
PubMed
7) Ueno H, Konishi T, Ishikawa Y et al : Histologic categorization of fibrotic cancer stroma in the primary tumor is an independent prognostic index in resectable colorectal liver metastasis. Am J Surg Pathol 38 : 1380-1386, 2014
PubMed
8) 上杉憲幸, 松田尚久, 九嶋亮治他 : 切除断端の病理学的評価からみた早期大腸癌内視鏡治療後の中・長期経過. 胃と腸 50 : 437-447, 2015
 
9) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
10) 工藤進英, 曽我淳, 下田聡他 : 大腸sm癌のsm浸潤の分析と治療方針-sm浸潤度分類について. 胃と腸 19 : 1349-1356, 1984
 
11) Haggitt RC, Glotzbach RE, Soffer EE et al : Prognostic factors in colorectal carcinomas arising in adenomas : implications for lesions removed by endoscopic polypectomy. Gastroenterology 89 : 328-336, 1985
PubMed
12) 坂谷新, 小泉浩一, 丸山雅一他 : 大腸sm癌の診断-X線診断の立場から. 胃と腸 26 : 726-735, 1991
 
13) Kitajima K, Fujimori T, Fujii S et al : Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma : a Japanese collaborative study. J Gastroenterol 39 : 534-543, 2004
PubMed
14) Matsuda T, Fukuzawa M, Uraoka T et al : Risk of lymph node metastasis in patients with pedunculated type early invasive colorectal cancer : A retrospective multicenter study. Cancer Sci 102 : 1693-1697, 2011
PubMed
15) Tateishi Y, Nakanishi Y, Taniguchi H et al : Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma. Mod Pathol 23 : 1068-1072, 2010
PubMed
16) Kojima M, Shimazaki H, Iwata K et al : Pathological diagnostic criterion of blood and lymphatic vessel invasion in colorectal cancer : a framework for developing an objective pathological diagnostic system using the Delphi method, from the Pathology Working Group of the Japanese Society for Cancer of the Colon and Rectum. J Clin Pathol 66 : 551-558, 2013
 
17) 江頭由太郎, 芥川寛, 枝川豪他 : 大腸SM癌のリンパ節転移に関する病理学的因子の研究-組織型の評価を中心に. 胃と腸 44 : 1229-1240, 2009
 
18) 河内洋, 江石義信, 渡辺英伸他 : SM癌治療における簇出の意義. 武藤徹一郎監修 : 大腸疾患NOW 2009, 日本メディカルセンター, 2009, pp127-132
 
19) Ueno H, Mochizuki H, Hashiguchi Y et al : Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 127 : 385-394, 2004
PubMed
20) 味岡洋一, 河内洋, 田中信治 : 大腸pSM癌に対する内視鏡治療根治基準の拡大 : 根治基準拡大に向けて解決すべき病理学的問題点-SM 浸潤距離. 胃と腸 46 : 1453-1458, 2011
 

第4部 臨床との連携

P.255 掲載の参考文献
1) 工藤進英 : 早期大腸癌-平坦・陥凹型へのアプローチ, 医学書院, 1993
 
2) Wada Y, Kudo S, Kashida H et al : The diagnosis of colorectal lesions with the magnifying narrow-band imaging system. Gastrointest Endosc 70 : 522-531, 2009
 
3) 河野弘志, 鶴田修, 有田桂子他 : 通常内視鏡診断の現状-色素内視鏡も含めて (1) 内視鏡診断の基本. Intestine 13 : 105-111, 2009
 
4) 津田純郎, 菊池陽介, 佐藤茂他 : 大腸腫瘍性病変の通常内視鏡診断はどこまで病理診断に迫れるか. 胃と腸 34 : 1623-1633, 1999
 
5) 斉藤裕輔, 田中信治, 鶴田修他 : 大腸微小病変に対する内視鏡診断-通常内視鏡診断. 胃と腸 52 : 1526-1533, 2017
 
6) 大腸癌研究会編 : 大腸癌治療ガイドライン 医師用 2019年版, 金原出版, 2019 (http://www.jsccr.jp/guideline/2019/index_guide.html) [2021年3月閲覧]
 
7) 鶴田修, 佐藤寧, 工藤進英他 : 大腸 2) 観察法. 消化器内視鏡ハンドブック, 日本メディカルセンター, 2012, pp329-340
 
8) Sano Y, Tanaka S, Kudo SE et al : Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team. Dig Endosc 28 : 526-533, 2016
PubMed
9) Kudo S, Hirota S, Nakajima T et al : Colorectal tumours and pit pattern. J Clin Pathol 47 : 880-885, 1994
PubMed
10) 鶴田修, 有馬信之, 豊永純他 : 早期大腸癌の深達度診断-内視鏡および実体顕微鏡所見を中心に. 胃と腸 29 : 85-97, 1994
 
11) 工藤進英 : 大腸pit pattern診断, 医学書院, 2010
 
12) 唐原健, 鶴田修, 河野弘志他 : 輪郭不明瞭VI型pitの意義. 早期大腸癌 11 : 403-408, 2007
 
13) Kudo SE, Wakamura K, Ikehara N et al : Diagnosis of colorectal lesions with a novel endocytoscopic classification-a pilot study. Endoscopy 43 : 869-875, 2011
PubMed
14) Kudo SE, Misawa M, Wada Y et al : Endocytoscopic microvasculature evaluation is a reliable new diagnostic method for colorectal lesions (with video). Gastrointest Endosc 82 : 912-923, 2015
PubMed
15) Kudo SE, Mori Y, Wakamura K et al : Endocytoscopy can provide additional diagnostic ability to magnifying chromoendoscopy for colorectal neoplasms. J Gastroenterol Hepatol 29 : 83-90, 2014
PubMed
16) 工藤進英 : 大腸EC分類 (超拡大内視鏡) 〔EC Classification for Colorectal Cancer〕. 胃と腸 54 : 680-681, 2019
 
P.262 掲載の参考文献
1) Bosset JF, Collette L, Calais G et al : Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 : 1114-1123, 2006
PubMed
2) 大腸癌研究会編 : 大腸癌治療ガイドライン 医師用 2019年版, 金原出版, 2019 (http://www.jsccr.jp/guideline/2019/index_guide.html) [2021年3月閲覧]
 
3) Tournigand C, Andre T, Achille E et al : FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer : a randomized GERCOR study. J Clin Oncol 22 : 229-237, 2004
PubMed
4) Wong R, Cunningham D, Barbachano Y et al : A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection. Ann Oncol 22 : 2042-2048, 2011
 
5) Folprecht G, Gruenberger T, Bechstein W et al : Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetux-imab in a multidisciplinary concept (CELIM study). Ann Oncol 25 : 1018-1025, 2014
PubMed
6) Shia J, Guillem JG, Moore HG et al : Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol 28 : 215-223, 2004
PubMed
7) Shia J, McManus M, Guillem JG et al : Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy. Am J Surg Pathol 35 : 127-134, 2011
PubMed
8) Wheeler JM, Warren BF, Jones AC et al : Preoperative radiotherapy for rectal cancer : implications for surgeons, pathologists and radiologists. Br J Surg 86 : 1108-1120, 1999
PubMed
9) Fajardo LF : The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol 44 : 13-22, 2005
PubMed
10) Li Chang HH, Leeper WR, Chan G et al : Infarct-like necrosis : a distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy. Am J Surg Pathol 36 : 570-576, 2012
 
11) Ishida K, Uesugi N, Hasegawa Y et al : Proposal for novel histological findings of colorectal liver metastases with preoperative chemotherapy. Pathol Int 65 : 367-373, 2015
PubMed
12) Rubbia-Brandt L, Audard V, Sartoretti P et al : Severe hepatic sinusoidal obstruction associated with oxaliplatinbased chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15 : 460-466, 2004
 
13) Vauthey JN, Pawlik TM, Ribero D et al : Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24 : 2065-2072, 2006
 
14) Mandard AM, Dalibard F, Mandard JC et al : Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73 : 2680-2686, 1994
PubMed
15) Dworak O, Keilholz L, Hoffmann A : Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12 : 19-23, 1997
 
16) Rodel C, Martus P, Papadoupolos T et al : Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23 : 8688-8696, 2005
PubMed
17) Langer R, Becker K : Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy. Virchows Arch 472 : 175-186, 2018
PubMed
18) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
19) Kojima M, Ishii G, Yamane Y et al : Area of residual tumor beyond the muscular layer is a useful predictor of outcome in rectal cancer patients who receive preoperative chemoradiotherapy. Pathol Int 59 : 857-862, 2009
PubMed
20) Rubbia-Brandt L, Giostra E, Brezault C et al : Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 18 : 299-304, 2007
PubMed
21) Blazer DG 3rd, Kishi Y, Maru DM et al : Pathologic response to preoperative chemotherapy : a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 26 : 5344-5351, 2008
PubMed
22) Ishida K, Tamura A, Kato K et al : Correlation between CT morphologic appearance and histologic findings in colorectal liver metastasis after preoperative chemotherapy. Abdom Radiol (NY) 43 : 2991-3000, 2018
PubMed
P.268 掲載の参考文献
1) Zauber AG, Winawer SJ, O'Brien MJ et al : Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366 : 687-696, 2012
 
2) Winawer SJ, Zauber AG, O'Brien MJ et al : Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 328 : 901-906, 1993
 
3) Matsuda T, Fujii T, Sano Y et al : Randomized comparison of surveillance intervals after colonoscopic removal of adenomatous polyps : Results from the Japan Polyp Study. Gastroenterology 146 : S161-S162, 2014
 
4) Hassan C, Quintero E, Dumonceau JM et al : Post-polypectomy colonoscopy surveillance : European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 45 : 842-851, 2013
PubMed
5) Gupta S, Lieberman D, Anderson JC et al : Recommendations for follow-up after colonoscopy and polypectomy : a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 158 : 1131-1153, 2020
PubMed
6) 日本消化器病学会編 : 大腸ポリープ診療ガイドライン 2020, 改訂第2版, 南江堂, 2020
 
7) 斎藤豊, 岡志郎, 河村卓二他 : 大腸内視鏡スクリーニングとサーベイランスガイドライン. Gastroenterol Endosc 62 : 1519-1560, 2020
 
8) 大腸癌研究会編 : 大腸癌治療ガイドライン医師用 2019年版, 金原出版, 2019 (http://www.jsccr.jp/guideline/2019/index_guide.html) [2021年3月閲覧]
 
9) 田中信治, 樫田博史, 斎藤豊他 : 大腸ESD/EMRガイドライン (第2版). Gastroenterol Endosc 61 : 1321-1344, 2019
 
10) Matsuda T, Fujii T, Sano Y et al : Five-year incidence of advanced neoplasia after initial colonoscopy in Japan : a multicenter retrospective cohort study. Jpn J Clin Oncol 39 : 435-442, 2009
PubMed
11) Hassan C, Wysocki PT, Fuccio L et al : Endoscopic surveil lance after surgical or endoscopic resection for colorectal cancer : European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) Guideline. Endoscopy 51 : 266-277, 2019
PubMed
12) Ikematsu H, Yoda Y, Matsuda T et al : Long-term outcomes after resection for submucosal invasive colorectal cancers. Gastroenterology 144 : 551-559, 2013
PubMed
13) Meyerhardt JA, Mangu PB, Flynn PJ et al : Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer : American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol 31 : 4465-4470, 2013
 
14) Benson AB 3rd, Venook AP, Cenderquist L : Colon Cancer, Version I. 2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 15 : 370-398, 2017
 
15) Labianca R, Nordlinger B, Beretta GD et al : Early colon cancer : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24 : 64-72, 2013
 
16) Kahi CJ, Boland CR, Dominitz JA et al : Colonoscopy surveillance after colorectal cancer resection : recommendations of the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 150 : 758-768, 2016
PubMed
17) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018
 
18) Lieberman DA, Rex DK, Winawer SJ et al : Guidelines for colonoscopy surveillance after screening and polypectomy : a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143 : 844-857, 2012
PubMed
P.277 掲載の参考文献
1) 国立がん研究センターがん対策情報センター : 全国がん死亡データ (1958年～2019年) (https://ganjoho.jp/reg_stat/statistics/dl/index.html) [2021年3月閲覧]
 
2) 大腸癌研究会 : 大腸癌治療ガイドライン 医師用 2019年版, 金原出版, 2019 (http://www.jsccr.jp/guideline/2019/index_guide.html) [2021年3月閲覧]
 
3) 岡志郎, 堀田欣一, 斎藤豊 : I. 内視鏡領域に関して. 癌と化学療法 46 : 1701-1703, 2019
Medical*Online
4) 斎藤豊, 岡志郎, 堀田欣一 : 内視鏡領域の主な改訂ポイント-ESDの適応とSM癌のフォローアップ. 臨床外科 74 : 948-950, 2019
 
5) 上野秀樹, 神藤英二, 梶原由規他 : II. 大腸癌治療ガイドライン2019年版における術式に関する改訂ポイント. 癌と化学療法 46 : 1704-1708, 2019
Medical*Online
6) 齋藤稔史, 茂原富美, 青柳康子他 : 腹腔鏡手術 横行結腸癌, 下行結腸癌, 直腸癌などの適応. 臨床外科 74 : 952-956, 2019
 
7) Kitano S, Inomata M, Mizusawa J et al : Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404) : a phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol 2 : 261-268, 2017
PubMed
8) 大腸癌研究会編 : 大腸癌取扱い規約, 第9版, 金原出版, 2018, pp38-39
 
9) 上野秀樹 : 側方郭清-術前診断と適応. 臨床外科 74 : 958-963, 2019
 
10) Fujita S, Mizusawa J, Kanemitsu Y et al : Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212) : a multicenter, randomized controlled, noninferiority trial. Ann Surg 266 : 201-207, 2017
 
11) 橋口陽二郎, 小澤毅士, 松田圭二 : 大腸癌治療ガイドライン 2019, 知っておくべき主な改訂ポイント- [改訂ポイント対照表つき]. 臨床外科 74 : 940-947, 2019
 
12) 岡崎聡, 石川敏昭, 植竹宏之 : 外科医が行う補助化学療法. 臨床外科 74 : 972-977, 2019
 
13) 井上博登, 山崎健太郎 : 外科医が知っておくべき進行再発切除不能癌の治療戦略-腫瘍占居部位とマーカー. 臨床外科 74 : 978-982, 2019
 
14) 谷口浩也 : III. 薬物療法領域に関して. 癌と化学療法 46 : 1709-1713, 2019
Medical*Online
15) 江頭徹哉, 谷口浩也 : 外科医のための免疫チェックポイント阻害薬の基礎知識. 臨床外科 74 : 984-988, 2019
 
16) 石黒めぐみ : 大腸ステントの適応と薬物療法. 臨床外科 74 : 965-970, 2019
 
P.283 掲載の参考文献
1) Fearon ER : Molecular genetics of colorectal cancer. Annu Rev Pathol 6 : 479-507, 2011
PubMed
2) Okugawa Y, Grady WM, Goel A : Epigenetic alterations in colorectal carcer : emerging biomarkers. Gastroenterology. 149 : 1204-1225, 2015
 
3) Naito Y, Takahashi H, Shitara K et al : Feasibility study of cancer genome alterations identified by next generation sequencing : ABC study. Jpn J Clin Oncol 48 : 559-564, 2018
PubMed
4) 大腸癌研究会編 : 大腸癌治療ガイドライン 医師用 2019年版, 金原出版, 2019 (http://www.jsccr.jp/guideline/2019/index_guide.html) [2021年3月閲覧]
 
5) Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D et al : RAS oncogenes : weaving a tumorigenic web. Nat Rev Cancer 11 : 761-774, 2011
 
6) Bos JL : Ras oncogenes in human cancer : a review. Cancer Res 49 : 4682-4689, 1989
 
7) Spano JP, Lagorce C, Atlan D et al : Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann Oncol 16 : 102-108, 2005
PubMed
8) Pines G, Kostler WJ, Yarden Y : Oncogenic mutant forms of EGFR : lessons in signal transduction and targets for cancer therapy. FEBS Lett 584 : 2699-2706, 2010
PubMed
9) Nakayama I, Hirota T, Shinozaki E : BRAF mutation in colorectal cancers : from prognostic marker to targetable mutation. Cancers 12 : 3236, 2020
 
10) Yoshino T, Arnold D, Taniguchi H et al : Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer : a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. Ann Oncol 29 : 44-70, 2018
PubMed
11) Grady WM, Carethers JM : Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135 : 1079-1099, 2008
PubMed
12) Le DT, Uram JN, Wang H et al : PD-1 Blockade in tumors with mismatch-repair deficiency. N Eng J Med 372 : 2509-2520, 2015
 
13) Diaz LA, Marebelle A, Delord JP et al : Pembrolizmab therapy for microsatellite instability high (MSI-H) colorectal cancer (CRC) and non-CRC. J Clin Oncol ; 35 : 3071, 2017
 
14) 日本病理学会編 : ゲノム研究用・診療用病理組織検体取扱い規程, 羊土社, 2019
 
15) 田村智英子 : NGS時代の遺伝性腫瘍診療における現状と課題. 最新医学 73 : 343-350, 2018
Medical*Online
16) 日本臨床腫瘍学会編 : 大腸がん診療における遺伝子関連検査等のガイダンス, 第4版, 金原出版, 2019
 

書評

最近チェックした商品履歴

Loading...